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Chapter 1
Introduction
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Complex Regional Pain Syndrome (CRPS) is a potentially incapacitating syndrome, that may 
occur after a minor injury or an operation applied to a limb. CRPS has impact on all tissues and 
may impair all functions of that extremity, leading to severe disability and almost intractable 
pain. The spectrum of symptoms and signs is wide. The early phase is characterized by signs and 
symptoms of inflammation including excessive pain and impaired motor and sensory function. 
The late phase is characterized by trophic changes of all tissues. In approximately 10 percent of 
the cases CRPS occurs without a preceding trauma. Formerly CRPS was denominated as causal­
gia, algodystrophy, Sudecks atrophy or reflex sympathetic dystrophy. In 1994 the International 
Association for the Study of Pain (IASP)1,2 coined the term Complex Regional Pain Syndrome 
type I (CRPS I). In CRPS type II (causalgia) nerve damage must be present.
This thesis focuses only on CRPS I, as this syndrome is more prevalent than CRPS II. The patho­
physiological mechanism of CRPS I is still controversial. Currently, there are several theories 
that explain the signs and symptoms of CRPS I3. In the psychosocial theory it is assumed that 
patients with CRPS I have a psychological predisposition. Inactivity has been suggested as a 
causal factor. The reflex sympathethic dystrophy theory states that an abnormally hyperactive 
sympathetic reflex is responsible for the signs and symptoms4. Paul Sudeck was the first to 
propose that CRPS I could be the result of an exaggerated inflammatory response after injury 
or operation of an extremity5.
The reported incidence of CRPS I varies between 5.5 - 26.2 per 100,000 persons6,7. The incidence 
of CRPS I in adults is estimated 1 - 2% after fractures, 2 - 5% after a peripheral nerve damage and 
in 8 - 24% after a wrist fracture8,9.
CRPs i iN CHiLDREN
Complex Regional Pain Syndrome type I in children was regarded rarely occurring until the 
1970s, when several case series were reported10. Currently there is increased awareness and 
the number of small case series and clinical outcome studies is rapidly growing11-13. Failure 
to diagnose CRPS I leads to delayed management, unnecessary investigations and improper 
treatment, which may worsen the situation and aggravate suffering. In children the clinical 
presentation of CRPS I is, to a certain extent, different from adults and adolescents, reason why 
the syndrome sometimes is not recognised in an early stage14.
We have retrospectively studied all patients under 16 years of age with CRPS I, seen at the Rad­
boud University Nijmegen Medical Centre in the time period 1980 - 2003 and compared these 
data with 951 adult patients with CRPS I (Chapter 2). This study is the first that compares chil­
dren and adults with CRPS I, and contains also the largest number of paediatric CRPS I patients 
evaluated. Reported results of treatment of CRPS I in children are usually more favourable and
ìn t r o d u c t ìo n
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seem better than in adults13,14. Therefore we also investigated the quality of life (QoL) in adults 
who have been treated for childhood-onset CRPS I (Chapter 3).
ìn fla m m a t ìo n
Although the clinical presentation of CRPS I is well known8,15,16, the mechanism of the (chronic) 
pain and the underlying pathophysiology still remain subject of debate. In the acute phase 
CRPS I is characterized by signs and symptoms of inflammation within the periphery of the 
affected extremity. Observations supporting the inflammatory theory include:
(a) The dominance of clinical signs and symptoms of inflammation at onset - such as unex­
plained, severe pain, oedema, difference in skin temperature, difference in skin colour, and 
impaired function - in the affected extremity8,
(b) Increased extravasation of indium-labeled immunoglobulin as a sign of increased capillary 
permeability for macromolecules17,
(c) The involvement of oxygen free radicals18-20,
(d) Successful treatment with radical scavengers such as dimethyl sulfoxide (DMSO), manni- 
tol18,19, N-acetyl-l-cysteine and vitamin C21-23,
(e) Higher levels of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) in blister fluid in 
the involved extremity in comparison to the unaffected extremity24 and elevated levels in 
venous blood in CRPS I patients of IL-8 and soluble TNF receptor I/II25 and
(f) Successful intervention in a pilot study with anti-TNF26.
ra d íc a ls
One of the most important features of inflammation is an excessive production of Reactive 
Oxygen and Nitrogen Species (RONS). Both clinical and experimental evidence support the 
theory that an excessive regional inflammatory response, including the production of RONS, 
contributes to the development of CRPS I and causes tissue damage8,17,27,28. We hypothesized 
that the increased capillary permeability, as part of an exaggerated inflammatory response, 
may be due to endothelial damage caused by oxygen radical species directly or mediated by 
polymorphonuclear leukocytes. To verify this hypothesis we performed a clinical study in which 
we analyzed radiolabeled autologous leukocyte imaging of both hands in patients with CRPS I 
of one upper extremity after a fracture or operation of the hand, comparing the affected with 
the unaffected hand (Chapter 4).
Several animal models are currently used to study the underlying mechanism(s) resulting in 
CRPS. In the animal model described by Bennet and Xie29, a peripheral mononeuropathy is 
induced in the rat by placing loosely constrictive ligatures around the common sciatic nerve
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at mid-thigh level, leading to nerve damage by chronic compression. Following this type of 
partial peripheral nerve injury, also known as the chronic constriction injury (CCI) model, the 
rat develops sensory, autonomic and trophic abnormalities and alterations in pain sensation, 
resembling the signs and symptoms as seen in CRPS patients. In this CCI model, formation of 
oxygen free radicals and nitric oxide have been shown to contribute to the hyperalgesia30-32. 
In order to analyse oxidative stress in the CCI model, we used recently developed spin-trap 
techniques and determined endogenous antioxidants such as glutathione, ceruloplasmin and 
transferrin (Chapter 5).
As RONS are closely involved in the development of CRPS I, our department developed an 
animal model of free radical induced soft tissue damage by continuous intra-arterial infusion 
of the free radical donor tert-butylhydroperoxide (Tert-BuOOH) in one hind limb of non­
anaesthetized rats, without inducing ischemia33. In this model injection with the antioxidant 
N-acetyl-l-cysteine, which can replenish the intracellular antioxidant glutathione, reduced 
pain sensations, reduced vascular permeability, reduced the observed soft tissue damage and 
shortened the repair period34. To further investigate oxidative stress in this animal model of 
free radical induced soft tissue injury, we determined RONS and measured antioxidant levels 
(Chapter 6).
v e n o u s  o xyg en  saturatìo n
Stolte et al. found in 1970 elevated venous oxygen saturation (SvO2) levels in CRPS I patients35. 
High SvO2 levels at rest are characteristic of a condition in which oxygen extraction is impaired, 
as it reflects the inability of tissues to utilize oxygen despite sufficient supply36. Furthermore, 
phosphorus nuclear magnetic resonance spectroscopy (PNMRs) in skeletal muscle of limbs with 
CRPS I, points to cellular hypoxia by abnormally high inorganic phosphate to phosphocreatine 
ratios at rest27 and by rapid depletion of phosphocreatine upon skeletal muscle exercise fol­
lowed by a slow recovery of phosphocreatine levels at subsequent rest36. In patients with acute 
CRPS I, our department also found significantly elevated SvO2 levels, obtained from the vena 
cubiti in the affected upper extremity, as compared to samples obtained from the unaffected 
contralateral limb36,37. However, in CRPS I patients any invasive procedure, such as performing a 
venous puncture, may increase the severity or recurrence of CRPS I in an affected limb, or induce 
CRPS I in a healthy limb8. In view of this, we measured peripheral oxygen saturation levels with 
a non invasive pulse oximeter, but could not detect any differences (data not published). We 
also assessed capillary oxygen saturation levels and lactate levels in the affected limb of acute 
CRPS I patients (Chapter 7). We assessed oxygen utilization in our animal model of free radical 
induced soft tissue injury, mimicking clinical signs and symptoms of CRPS I, by investigating 
SvO2 and lactate levels (Chapter 6). In Chapter 8 we examined patients with late dystrophic or 
atrophic end stage CRPS I requiring amputation, in order to look for evidence of diminished
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oxygen consumption, by analyzing venous blood samples, and performing microscopic analy­
sis and mitochondrial function studies on tissue obtained from the amputated extremity. 
Based on the high SvO2 levels found, we hypothesised four possibilities: first, a deficient auto­
regulation of microcirculation, resulting in a widely open capillary bed, while only a small 
fraction of the oxygen supplied is consumed due to hyper-perfusion of some capillaries and 
inadequate perfusion of others; second, the presence of increased flow through non-nutritive 
pathways, such as through arterio-venous anastomoses38; third, a diffusion problem for oxygen 
between the erythrocytes and the mitochondria, especially due to changes in the endothelial 
cell and the capillary basement membrane; and finally, minimal oxygen extraction due to 
mitochondrial dysfunction. Mitochondrial dysfunction seemed a plausible cause for the high 
SvO2 levels found, as dysfunctional mitochondria might explain the PNMRs findings in CRPS 
I patients, with increased anorganic phosphate to creatine phosphate ratios at rest, pointing 
to cellular hypoxia27. However, mitochondrial function has never been investigated in CRPS 
I patients before. We assessed in vitro mitochondrial function by using a model of isolated 
skeletal muscle mitochondria subjected to the radical donor Tert-BuOOH39, which we also have 
used in our animal model (Chapter 6). We also found a manner to investigate mitochondrial 
function in CRPS I patients, without the risk of inducing or exacerbating CRPS I in an affected 
limb, by analyzing amputated extremities of chronic end stage CRPS I patients on mitochon­
drial dysfunction (Chapter 9).
Chapter 10 summarizes our main conclusions and formulates recommendations for future 
research in the field of CRPS I.
a im s  o f t h is  t h e s is :
- To study the clinical presentation and prognosis of CRPS I in children and adults.
- To study some fundamental aspects of inflammation in CRPS I; (1) by investigating the role 
of oxygen free radicals in patients and in animal experiments and (2) by investigating SvO2 
levels and factors possibly involved in impaired oxygen extraction, such as capillary density, 
capillary membrane thickness, and mitochondrial function.
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a bstra c t
Background:
Complex Regional Pain Syndrome type I (CRPS I) is a potentially incapacitating syndrome which 
can occur after a minor injury or operation to a limb. It is a disorder characterized by pain, 
sensory and motor disturbances. CRPS I is well known in adults but a relatively new diagnostic 
entity in children. The clinical presentation of CRPS I in children is, to some extent, different 
from adults and therefore sometimes not recognized early. The aim of this study was to search 
for differences in patient characteristics between children and adults with CRPS I.
Methods:
We have performed a retrospective chart review of 78 children (age < 16 year) with CRPS type I 
and compared the data with those of 951 adults with CRPS type I.
Results:
The child population consisted predominantly of girls, and older children (median age 13 years). 
The child population differed from adults in that the skin temperature of the involved extremity 
at onset was more often cooler, that the lower extremity was involved more frequently, and 
that neurological and sympathetic symptoms were less pronounced.
Conclusion:
In several aspects, CRPS I in children has a different presentation than in adults.
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Complex Region Pain Syndrome type I (CRPS I) is a potentially incapacitating syndrome 
which can occur after a minor injury or operation to a limb. In approximately 10 percent of 
the patients, CRPS I occurs without a previous injury1. CRPS I has an impact on all tissues 
and can impair all functions of that extremity, possibly resulting in severe impairment and 
therapy-resistant pain. The pathophysiological mechanism of CRPS I is not yet elucidated. 
Several mechanisms are hypothesized in the generation and maintenance of CRPS I such as 
a psychological predisposition, inactivity, increased sympathetic activity and an exaggerated 
regional inflammatory response2. Paul Sudeck was the first to propose that CRPS I could be the 
result of an exaggerated regional inflammatory response in the affected extremity after injury3. 
Later on this hypothesis was corroborated by findings that in the acute phase extravasation 
of Indium-immunoglobulin4, increased concentration of leucocytes5 and oxygen free radicals 
could be demonstrated within the affected part6,7.
Formerly CRPS was denominated causalgia, algodystrophy, Sudecks atrophy or reflex sympa­
thetic dystrophy. In 1994 the International Association for the Study of Pain (IASP)8,9 coined the 
term Complex Regional Pain Syndrome type I (CRPS I). In CRPS type II (causalgia) nerve damage 
must be present.
The incidence of CRPS I in adults is estimated at 1 - 2% after a fracture, 2 - 5% after a peripheral 
nerve lesion and even 8 - 24% after a fracture of the distal radius1,10. The clinical presentation 
of CRPS I in children is, to some extent, different from adults and therefore sometimes not 
recognized early. We have retrospectively studied all charts of patients under 16 years of age 
with CRPS I, seen at the Radboud University Nijmegen Medical Centre during 24 years.
patients an d  m eth o d s
We performed a retrospective chart analysis of the history, signs and symptoms and treatment 
of all children under age of 16 years with CRPS I, seen between January 1980 and January 2004 
at the Department of Paediatric Surgery and General Surgery. Diagnosis was based on the cri­
teria formulated by Veldman et al1. The following diagnostic criteria were used in establishing 
the diagnosis of CRPS I:
1. Presence of at least 4 of the following 5 signs and symptoms: unexplained diffuse pain and 
tenderness in the distal part of the extremity, difference in skin colour in relation to the 
healthy symmetrical limb, diffuse oedema, difference in skin temperature in relation to the 
healthy symmetrical limb and limited range of movement.
2. The above signs and symptoms increase during exercise.
in t r o d u c t io n
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3. The above signs and symptoms are present in an area much larger than the area of primary 
injury or operation and including the area distal to the primary injury.
These data were compared with 951 adult CRPS I patients, which have been selected on the 
basis of the criteria of Veldman et al. from all consecutive patients seen during the period Janu­
ary 1984 till September 1997 for signs and symptoms of CRPS I at the outpatient clinic of the 
university hospital, the Department of General Surgery.
These adults were documented prospectively according to an extensive protocol and the data 
entered into a computerized patient record file. Part 1 of this file consists of data obtained by 
a questionnaire, including age at the time of the visit to our outpatient clinic, age at the onset 
of the disease, gender, the initiating cause of the CRPS I (e.g., trauma, surgery, spontaneous, 
others), the patient's description of the skin temperature of the affected extremity at the onset 
of the CRPS I, the presence of CRPS I in another extremity, and modes of treatment before the 
patient visited our outpatient clinic. Part 2 of the file included data obtained by physical exami­
nation of the patient as described by Veldman et al. and Van der Laan et al.1,11. The pain within 
the affected area was scored by the visual analogue scale. Oedema (present or absent) skin 
colour (blue, red, normal) and skin temperature (cold, warm, normal) of the affected extremity 
were assessed clinically and documented in comparison to the unaffected contralateral limb. 
Differences between children and adults in characteristic were described by means or propor­
tions and the corresponding confidence intervals for the difference. Continuous and categori­
cal variables were compared using the t-test and the chi-square test, respectively. Differences 
between children and adults in time-to-event variables were described by median interval 
times as estimated by the Kaplan-Meier method and compared using the Breslow-Gehan- 
Wilcoxon test. A p-value below 0.05 was taken to indicate statistical significance.
resu lts
In total we identified 78 children (< 16 years) and 951 adults (age > 16 years) with CRPS I fulfill­
ing the criteria of Veldman et al. Sixty children (76.9%) and 840 adults (88.3%) fulfilled the IASP 
criteria for CRPS I8,9, and none fulfilled the criteria for CRPS II. Clinical characteristics of both 
populations are shown in Table I. In the paediatric population 85.9% were female, comparing to 
74.9% in the adult population (p = 0.03). The median age in the paediatric population was 13.0 
years (range 5 - 16 years) and 43.8 years (range 17 - 96) in the adult population. In children one 
upper extremity was affected in 23.3%, one lower extremity in 72.6% , both upper or both lower 
extremities in 4.1%. The upper extremity in adults was more frequently involved (60.8%) than 
the lower extremity in children (p < 0.001). In children, CRPS I was caused by a minor injury in 
62.5%, usually as a result of an ankle sprain. In 6 children (8.3%) no precipitating factor could be 
identified (Table 1). In children CRPS I appeared to be more common during the winter season
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Table 1. Clinical characteristics of adults and children with CRPS I.
Adults
%  (n/n_ev)
Children
%  (n/n_ev)
p-value
Gender 0.03
Female 74.9 (712/951) 85.9 (67/78)
Male 25.1 (239/951) 14.1 (11/78)
Median age in years (range) 43.8 (16 - 96) 13 (5 - 16)
Upper/lower < 0.001
Upper extremity involved 60.8 (578/951) 23.3 (17/73)
Lower extremity involved 39.2 (373/951) 72.6 (53/73)
Upper and lower extremity involved 0 4.1 (3/73)
Left/right < 0.001
Right 51.5 (402/780) 47.4 (37/78)
Left 48.5 (378/780) 48.7 (38/78)
Bilateral involvement 0 3.8 (3/78)
History of trauma < 0.001
None 10.6 (98/926) 8.3 (6/72)
Mild (contusion, sprain/strain) 32.2 (298/926) 62.5 (45/72)
Severe (fracture, post surgical) 57.2 (530/926) 29.2 (21/72)
n_ev = number of evaluable patients
(32.4%) as compared to spring (23.5%), summer (20.6%) and fall (23.5%) (p = 0.46). In adults the 
incidence of injuries was equally distributed between seasons.
The signs and symptoms at first consultation at our outpatient clinics are summarized in Table
2. Not from all patients data were complete. The main complaints in both populations were 
pain, a difference in skin colour and skin temperature, a limited active range of motion, and an 
increase in complaints after exercising the affected extremity. In the paediatric population the 
affected extremity was mostly cold (71.8%) with a median temperature difference of -1.3°C and 
blue discoloration of the skin. In the adult population the affected extremity mostly was warm 
(55.1%). In the paediatric population the median visual analogue score (VAS) was 7 (range 0 - 
10, SD 2.8), in the adult population 4 (range 0 - 10, SD 2.6) (p < 0.001).
The estimated median interval between injury and CRPS I symptoms was 0.14 weeks (range
0 - 313.1, interquartile range 0 - 2) for adults (n = 647) versus 0.57 weeks (range 0 - 26.7, inter­
quartile range 0.14 - 2.71) for children (n = 64). This is significant longer than adults (p = 0.0009, 
Breslow-Gehan-Wilcoxon test). The estimated median interval between CRPS I symptoms and 
first attendance at our outpatient clinic was 19.1 weeks (range 0 - 1043.6, interquartile range 
9.1 - 49.4) for adults (n = 719) versus 11.9 weeks (range 0 - 205.2, interquartile range 3.7 - 28.1) 
for children (n = 66). This is significantly shorter than for adults (p = 0.0002, Breslow-Gehan- 
Wilcoxon test).
During the study period several treatment strategies for children with CRPS I have been 
implemented; consisting of a combination of medical treatment (scavengers, vasodilators, pain 
medication), physical therapy and psychological counselling.
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Table 2. Signs and symptoms of adults and children with CRPS I.
Signs and symptoms Adults Children 95%-CI p-value
(%) (n /n-ev) (%) (n /ev) for difference
Inflammatory
Pain 99.9 (950/951) 97.4 (76/78) [0.5 , 8.8] <0.01
Difference in skin colour 93.3 (887/951) 82.1 (64/78) [4.1 , 21.3] <0.01
Oedema 77.5 (737/951) 39.7 (31/78) [26.3 , 48.2] <0.01
Difference in skin temperature 90.9 (864/951) 87.2 (68/78) [-2.4 , 13.0] <0.01
- Cooler 44.9 (427/951) 71.8 (56/78) [-36.2, -15.6] <0.01
Unexplainable limited range of motion 90.1 (857/951) 62.8 (49/78) [17.2 , 38.5] <0.01
Increase of complaints after exercise 82.3 (763/927) 70.5 (55/78) [2.5 , 22.9] 0.7
Neurological
Hypaesthesia 75.4 (674/894) 46.2 (36/78) [17.9 , 40.2] <0.01
Hyperpathy 80.8 (705/873) 52.6 (41/78) [17.1 , 39.4] <0.01
Dyscoordination 47.3 (365/771) 23.4 (18/77) [12.8 , 32.8] <0.01
Tremor 43.6 (371/850) 22.1 (17/77) [10.6 , 30.1] <0.01
Involuntary movements 28.5 (212/744) 23.1 (18/78) [-5.5 , 14.0] 0.3
Skeletal muscle spasm 21.7 (185/851) 21.4 (6/28) [-18.0 , 11.9] 1.0
Paresis 93.2 (670/719) 48.7 (38/78) [33.4 , 55.4] <0.01
Pseudo paralysis 17.5 (152/867) 18.2 (14/77) [-11.0, 6.9] 0.9
Myoclonus 8.1 (51/630) 14.1 (11/78) [-15.6 , 0.5] 0.07
Atrophy
Skin 40.2 (347/864) 7.8 (6/77) [23.6 , 37.7] <0.01
Nails 26.1 (216/827) 11.7 (9/77) [4.9 , 20.7] <0.01
Subcutaneous tissue 25.9 (200/771) 6.5 (5/77) [11.1 , 24.3] <0.01
Skeletal muscle 45.8 (374/816) 32.5 (25/77) [1.8 , 23.4] 0.02
Sympathetic signs and symptoms
Abnormal sweating 42.3 (343/810) 23.4 (18/77) [7.9 , 27.7] <0.01
Complications
Chronic infection 5.5 (24/440) 1.3 (1/77) [-1.8 , 6.9] 0.1
Spontaneous haematoma 47.2 (178/377) 6.5 (5/77) [31.4 , 47.0] <0.01
n_ev = number of evaluable patients
Not in all the charts all symptoms were documented
Twenty-two children (28.2%) suffered a renewed episode of CRPS I. In fifteen of these cases 
this was the result of a new injury. Five children were seen with 2 new episodes, one child 
with three, and two children with four new episodes of CRPS I. In 60% of these relapses, the 
previously affected extremity was affected again. The signs and symptoms in the renewed 
episode were similar to those found at the first presentation in our hospital. At the moment 
of the retrospective chart review, 7 children were still being treated for CRPS I in our hospital.
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Once considered uncommon, currently there is increased awareness and recognition of CRPS
I in children. Complex Regional Pain Syndrome type I is mainly seen in children between the 
ages 12 to 14 years, with a range of 5 to 17 years12-16. The youngest child reported with CRPS I 
was 2.5 years old17. Why CRPS I develops predominantly in adolescent girls (in our study median 
age was 13 years) is not known18. Oestrogen dependent pain responses may explain sex differ­
ences19, while also psychosocial problems in this age group may play an important role20. No 
accurate data are available concerning the incidence and prevalence of CRPS I in children. In 
the present study, a minor injury, mostly an ankle sprain, induced CRPS I in 45% of the cases. 
In children no initiating event was found in 46% of the cases21, in our study this was only 8.3%. 
In children several signs and symptoms can be attributed to CRPS Ii3,i4,i6,22-24. The most com­
mon complaint is pain, excessive in relation to the severity of injury. In our study, children 
with CRPS I presented mainly with unexplained severe pain, with a colour and temperature 
difference (mostly cooler), an impaired active range of motion of the affected extremity. In one 
report of 70 children with CRPS I, pain was present in all, mechanical allodynia in 86%, oedema 
in 77%, a temperature difference in 77% (cold extremity) and a difference in skin colour in 
73%13,22,23. These findings compare reasonably with the present findings, except for oedema, 
which was seen in only 39.7% of our cases. This difference may be explained by the delayed 
presentation at our outpatient clinic, and/or by the fact that treatment had started prior to 
presentation. In the present series the upper extremity was affected in 23.3% of the patients, 
comparable to previous reports mentioning percentages between 13 and 39%13,22,23. Although 
documented in all series, it is not known why CRPS I in children presents more frequently in the 
lower extremity24.
Our results show there are significant differences between adults and children with CRPS I. Most 
remarkable differences are that in children with CRPS I; female predominance, lower extremity 
involvement, mostly colder temperature difference and less oedema compared to the opposite 
in adults with CRPS I. Despite these differences the present study shows that also in children 
CRPS I is characterized by classical signs and symptoms of inflammation - pain, oedema, discol­
oration, changes in temperature and impaired function. Also in children CRPS I develops more 
often after a minor injury. Treatment results seem comparable to these found in adults. Long 
term prognosis in children is similar to adults, according to a quality of life study in adults with 
onset of CRPS I in childhood25. In previous studies, CRPS I recurrence rates ranged from 28% to 
33%14,21. We also found a 28.2% recurrence rate between enrolment and follow-up. The child 
and his parents have to be instructed and prepared for a possible relapse, possibly following 
a new injury. Indeed a relapse may lead to anxiety, fear and pain, resulting in immobility and 
recurrence of CRPS I-like symptoms.
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There is no consensus concerning the criteria for diagnosing CRPS I in children13. In our opinion 
the criteria of Veldman et al. for CRPS I in adults can also be applied to children1. From our study 
group 60 (76.9%) children and 840 (88.3%) adults also fulfilled the IASP criteria for CRPS I8,9, 
none fulfilled the criteria for CRPS II.
Several protocols have been described for the treatment of CRPS in children, with various 
results. Most studies involved small groups or case reports. Treatment protocols currently 
recommended for children with CRPS I are physical therapy; advice on posture and movement, 
stimulation of the normal usage of the affected extremity, and psychological intervention to 
reduce fear of movement21.
We have provided clinical and experimental evidence that an excessive regional inflammatory 
response, including the production of reactive oxygen free radicals, may be involved in caus­
ing tissue damage in CRPS I1,4,26,27. Also the therapeutic effect of free radical scavengers has 
been well documented in adults28,29. We have managed children with CRPS I accordingly to a 
treatment protocol including scavengers. This retrospective study does not allow to make firm 
conclusions as to the treatment of children with CRPS I with scavengers and peripheral vasodi­
lators, a major confounding factor being the individualized co-medication and co-therapy (i.e. 
doses were adapted to each individual patient). Further investigations by means of randomized 
controlled trials should be performed to evaluate and validate the effect of scavenger therapy 
and peripheral vasodilators in children with CRPS I.
co n clusìo n
In this retrospective chart review 78 children (age < 16 year) with CRPS I are described and 
compared to 951 CRPS I adult patients. The child population consisted predominantly of girls 
and older children (median age 13 years).The child population differed from adults in that 
the skin temperature of the involved extremity at onset was more often cooler, that the lower 
extremity was involved more frequently, and that neurological and sympathetic symptoms 
were less pronounced. Increased awareness of CRPS I in children, acquaintance with signs and 
symptoms, use of diagnostic criteria and if necessary referral to a clinic with experience in treat­
ing children with CRPS I may lead to decreasing pain, suffering and quicker restore of function 
in children and adolescents with CRPS I.
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a bstra c t
Background:
The clinical presentation of Complex Regional Pain Syndrome type I (CRPS I) in children differs 
compared to the presentation in adults. Reported results of treatment of CRPS I in children are 
usually more favourable and seem better than the reported treatment of adults with CRPS I. 
We investigated the quality of life (QoL) in adults who have been treated for childhood-onset 
CRPS I.
Methods:
We performed a retrospective chart review on signs, symptoms and treatment of all patients, 
seen and treated for CRPS I in childhood (age < 16 years). At one time point a survey was sent by 
mail to all adult patients with onset CRPS I in childhood with a postal reminder after one month. 
The first part of the survey consisted of questions focused on the experience of chronic pain 
and other current complaints in the affected extremity. The second part consisted of a generic 
health-related quality of life instrument (SF-36).
Results:
Forty-two patients (75%) responded to our survey. The median follow-up period was 12 years 
(SD 4.7; range 2 - 22). Fifty-two percent of all patients complained about pain at the time of 
follow-up. Of the 12 symptoms and signs, 4 are improved, 1 is worse and the remainder are 
unchanged. Fifteen patients (33%) experienced one or more documented relapses. General 
health and physical functioning (2 out of 8 scales on the SF-36) were lower in patients com­
pared to those of the literature.
Conclusion:
In contrast to the literature, the prognosis of childhood-onset CRPS I seems less favourable 
than usually reported, and is comparable to the prognosis of the adult-onset CRPS I in view of a 
decreased quality of life and a large relapse percentage (33%) at long-term follow-up.
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in tro d u ct io n
Complex Region Pain Syndrome type I (CRPS I) is a potentially incapacitating syndrome which 
can occur after a minor injury or limb operation. In approximately 10 percent of patients, CRPS 
I occurs without previous injury. CRPS I impacts all tissues and can impair all functions of the 
affected extremity, possibly resulting in severe impairment and therapy-resistant pain1. At our 
department, children were managed according to a standardized treatment protocol, consist­
ing of free radical scavenger and vasodilator treatment, attention to painful trigger points and 
physical therapy, similar to the treatment for adults with CRPS I2. Since 1995, psychological 
counselling was added to the standard treatment protocol. Reported results of treatment of 
CRPS I in children are usually favourable and seem better than treatment reports of adults with 
CRPS I3-5. We therefore hypothesized that the quality of life is better in adults with childhood- 
onset CRPS I as compared to adults with adult-onset CRPS I. We conducted a follow-up study 
of adults with childhood-onset CRPS I at the Radboud University Nijmegen Medical Centre to 
evaluate their physical, social and psychological effects at long-term follow-up. These effects 
were measured with a health-related quality of life (HRQoL) instrument. The aim of this study 
was to investigate the HRQoL of adults patients with a childhood-onset of CRPS I.
patients a n d  m eth o d s
At first we performed a retrospective analysis of the history, signs and symptoms and treatment 
of all patients who have been seen and were treated for CRPS I in childhood (age < 16 years) 
between January 1980 and December 2003 at the Radboud University Nijmegen Medical 
Centre (RUNMC). Data were collected from patient charts and office notes and collected in a 
database. CRPS I was diagnosed based on the criteria as formulated by Veldman et al1. The 
following diagnostic criteria were used since the start of this study:
1. Presence of at least 4 of the following 5 signs and symptoms: unexplained diffuse pain and 
tenderness in the distal part of the extremity, difference in skin colour in relation to the 
healthy symmetrical limb, diffuse oedema, difference in skin temperature in relation to the 
healthy symmetrical limb and limited range of movement.
2. The above signs and symptoms increase during exercise.
3. The above signs and symptoms are present in an area much larger than the area of primary 
injury or operation and including the area distal to the primary injury.
After identification of the patients with childhood-onset CRPS I, a survey was sent by mail with 
a postal reminder after one month to only the adult patients (age > 16 years) with childhood- 
onset CRPS I. The survey was divided into two parts. The first part of the survey consisted of
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questions focused on the experience of chronic pain and other current complaints in the 
affected extremity. These results were compared with the signs and symptoms, documented at 
the first consult. The second part consisted of a HRQoL instrument, namely the Dutch version 
of the Medical Outcome Study Short Form-36 (SF-36)6. The SF-36 is made up of 36 items and 
standardized response choices. This instrument has been used in a variety of studies and also in 
several studies on musculoskeletal disorders and CRPS I. Psychometric properties of this instru­
ment have been studied in detail and are considered adequate7-9. The 36 items are converted 
to eight scales representing generic health domains. These eight health domains are: physical 
functioning (PF), role function-physical aspect (PR), bodily pain (BP), general health percep­
tion (GH), vitality (VT) social functioning (SF), role function - emotional aspect (RE) and mental 
Health (MH). Higher scores represent a better HRQoL in the particular domain PF, RP and BP 
are a measure of physical dimensions, RE and MH measure mental dimensions. GH, VT and SF 
correlate with both physical and mental domains.
All statistical analyses were conducted using SPSS (Statistical Package for the Social Sciences 
version 12.01 for Windows; SPSS Inc., Chicago, IL). The paired-sample t-test was used to 
compare the signs and symptoms between first consult and follow-up. A p-value of < 0.05 
was considered statistically significant. To identify possible prognostic factors regarding the 
relationship between short and long-term outcome measures (signs and symptoms as noted 
in the first part of the survey), location of CRPS I, and the history of trauma was estimated with 
linear regression analysis.
resu lts
Sixty-two adult patients were identified with childhood-onset CRPS I (age < 16 years), accord­
ing to the Veldman et al. criteria, and were approached to participate in this study1. One patient 
died from severe CRPS I (euthanasia), two patients refused for unknown reasons and three 
patients could not be located. Hence, 56 patients were available for the study. Forty-two (75%) 
responded to our survey (Table 1). At first consult, when the diagnosis of CRPS I was made, 
the median age of these patients was 13.2 years (SD 2.2, range 6 - 16). When the survey was 
conducted, the median age of the patients was 25.5 years (SD 4.8, range 16 - 34). Thirty-seven 
(88%) were female. The median follow-up period was 12 years (SD 4.7; range 2 - 22). All were 
Caucasian.
Table 2 shows the signs and symptoms both from the first consult and at follow-up. Fifty-two 
percent of all patients complained about pain at the time of follow-up. The initial median 
documented visual analogue score (VAS) at first visit at our outpatient clinic was 6.0 (SD 2.4; 
range 2 - 10), and at follow-up was 4.5 (SD 2.4; range 1 - 8.5). Patients reported that this pain 
increased with exposure to cold (36%) and/or heat (10%). Ten patients (23.8%) did not have any
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Table 1. Clinical characteristics of 42 adult patients with onset CRPS I in childhood.
Characteristics Descriptives
Female (%) 37 (88)
Median age in years (range) 25.5 (16 - 34)
Median follow-up in years (range) 12 (2 - 22)
History of trauma (%) 37 (88)
Upper extremity involved (%) 8 (19)
Lower extremity involved (%) 32 (76)
Upper and lower extremity involved (%) 2 (5)
Left (%) 23 (55)
Right (%) 17 (42)
Bilateral involvement (%) 2 (5)
Table 2. Signs and symptoms at time of first visit and at follow-up of 42 adult patients with onset CRPS I in
childhood (< 16 years).
First consult Follow-up p-value
n (%) n (%)
Pain 40 (95.2) 22 (52.4) < 0.0 1*
Increase of complaints after exercise 25 (59.5) 24 (57.1) 0.82
Hypersensitivity 6 (14.3) 14 (33.3) 0.03*
Decrease in tactile sense 21 (50.0) 8 (19.0) < 0.0 1*
Difference in skin colour 31 (73.8) 12 (28.6) < 0.0 1*
Difference in skin temperature 36 (85.7) 19 (45.2) < 0.0 1*
Swelling 14 (33.3) 8 (19) 0.35
Limited range of motion 25 (59.5) 19 (45.2) 0.57
Involuntary movements 10 (23.8) 7 (16.7) 0.78
Tremor 13 (30.9) 5 (11.9) 0.08
Decrease in muscle strength 15 (35.7) 15 (35.7) 0.66
Dyscoordination 11 (26.2) 5 (11.9) 0.32
* = p < 0.05
complaints at follow-up. Recurrence of signs and symptoms which could be attributed to CRPS
I, after treatment were found in 63% of the patients, but in the patient charts and office notes, 
only an objectively documented recurrence rate of 33% was found.
Results of the SF-36 are shown in Table 3. Analyzing gender differences, a significant difference 
was observed in 6 out of 8 domains (p < 0.05). On all eight domains, males scored better than 
females.
The linear regression analysis showed that the longer the follow-up period since the first atten­
dance at our outpatient clinic, the better patients scored on the domain role physical (p = 0.02). 
The age of the patient at the time of first consult did not significantly predict the outcome of 
the HRQoL scores, except for the general health domain. Neither the history of trauma nor the 
location of CRPS I was found to be prognostic factor.
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Table 3. Long-term follow-up SF-36 means scores (SD) of 42 Dutch adults with onset CRPS I in childhood.
Adults with onset CRPS I in childhood 
n = 42
1. Physical functioning 82.9 (20.4)
2. Role functioning physical 77.4 (36.1)
3. Bodily pain 79.8 (25.01)
4. General health 58.7 (25.9)
5.Vitality 67.7 (23.2)
6. Social functioning 83.03 (22.2)
7. Role functioning emotional 92.9 (22.7)
8. Mental health 78.0 (19.1)
DiSCUSSiON
The clinical presentation of Complex Regional Pain Syndrome type I (CRPS I) in children dif­
fers compared to the presentation in adults5. CRPS I is seen specifically in children from 12 
to 14 years, with a range of 5 to 17 years5,10-14. The youngest child reported with CRPS I was
2.5 years15. The reason for the predilection of adolescent girls to develop CRPS I is unknown,16 
although some suggest that psychosocial aspects may play a role17. No accurate data are avail­
able concerning the prevalence and incidence of CRPS I in children. After a median follow-up 
period of 12 years, only 23.8% of the patients was free of complaints. The reported long-term 
outcome of the children in our study appeared to be less favourable than previously published 
in other studies (Table 4)4,10-13,18,19,24. All of these studies, however, had a much shorter follow- 
up period.
To our knowledge, this is the first description of long-term outcomes expressed by health- 
related quality of life (HRQoL) in adults with childhood-onset CRPS I. Contrary to our hypothesis, 
the results of the present study showed that CRPS I outcome and prognosis in children seem 
comparable to adults. Most adults with childhood-onset of CRPS I have a poorer HRQoL as
Table 4. Outcome of CRPS I in childhood (< 16 years).
Study Children Favourable outcome Mean follow-up
n* n (%) years
Tan et al. (this study) 42 10 (24) 11.5
Wilder et al.11 70 32 (46) 2
Sherry et al.4 49 43 (88) 5.3
Murray et al.13 43 40 (93) 0.5
Greipp et al.18 27 1 (4) 4.2
Stanton et al.12 36 25 (69) unspecified
Lee et al.24 25 25 (100) 2.5
Bernstein et al.10 20 12 (60) 2.4
Low et al.19 20 18 (90) 2
* Final number of patients analyzed
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compared to a standard Dutch age-matched group (16 - 40 years) of 1585 healthy subjects of 
the general population20. Analyzing all 8 items of the SF-36, adults with childhood-onset CRPS I 
seem to have a lower physical health status but seem to have better emotional and mental 
health function as compared to normal controls. This emphasizes the major impact of this 
disease in patients confronted with CRPS I in childhood. Children may develop different coping 
strategies in these psychosocial domains, a phenomenon whose end result is also observed in 
adults operated in childhood for a benign disease21. However, the observations of these studies 
are in contrast to the observation, that paediatric cancer survivors usually have a good HRQoL 
and a higher rating of physical health and social-emotional functioning, possibly related to 
the change in the survivors outlook on life that resulted from the cancer experience, by which 
they may be much happier with the various details of life22. When comparing our results with 
65 Dutch adult patients with CRPS I diagnosed and treated in adulthood (mean age 50.2 years, 
SD 14.9), with a mean follow-up of 5.5 years for 3 HRQoL domains, comparable results for role 
physical 77.4 (36.1) versus 71.2 (40.8) and social functioning 83 (22.2) versus 82.7 (23.3) were 
observed7. The higher social emotional functioning we found in the childhood-onset CRPS I 
group 92.9 (22.7) as compared to the Dutch adolescent age-matched group ((84.1 (32.3)) and 
as compared to the adult-onset group ((78 (36.9)), may be explained by the higher proportion 
of females in this specific group, who may have different coping strategies than males23.
In line with the literature reports that describe a high recurrence rate of 27.5 - 50% in chil­
dren12,13,24, in our study a (well-documented) recurrence rate of 33% was found. Children and 
parents could therefore be prepared for the occurrence of episodes of recurrent complaints, 
which may lead to anxiety, fear and pain, and to immobility and renewed occurrence of CRPS 
I like symptoms. We preventively instructed them how to handle these episode of recurrent 
complaints by themselves, and most children were able to do so with occasionally some help in 
the first episode of the recurrence.
There are a number of alternative explanations why our findings, that long-term results after 
childhood-onset CRPS I do not differ much from adult-onset CRPS I, and are rather different 
from earlier literature reports. First, this study has all the drawbacks of a retrospective study. 
Second, the patient population studied, was comprised only of unselected patients referred to 
our university tertiary referral centre, which functions as the single reference centre for CRPS 
I in the Netherlands. It is therefore likely that the CRPS I patient populations evaluated else­
where consisted of a selected group of patients (selection bias) and also different therapeutic 
approaches may have been applied25. Primary care physicians and other general paediatricians 
would often consult or refer patients with CRPS I directly to the RUNMC. It can thus be argued 
that the patients included in our study do not comprise of a smaller subset of more severely 
affected patients, but constitutes a large, and probably unbiased group of children and ado­
lescent with CRPS I. Our multidisciplinary approach warrants equal treatments strategies for all
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patients. In our study group more females than males were included compared to the standard 
population. All other social demographics were almost equally distributed among the CRPS 
I patient group and the control groups. From many HRQoL studies and also in our study it is 
known that males show a slightly better HRQoL,20,26 but due to small sample size this pattern 
could not become visible. Third, there can be a definition bias as other studies used different 
inclusion criteria for the diagnosis of CRPS I. Currently there is no consensus concerning the 
criteria for this diagnosis in children. In our opinion the Veldman and Goris criteria,1 which have 
been developed by the RUNMC are more likely to be specific for CRPS I or II than the criteria 
used by Sherry and Weinman16. Retrospectively, we found that 81% of our patients fitted the 
criteria for CRPS I according to the International Association for the Study of Pain (IASP), and 
did not fulfill the criteria for CRPS II27,28. Fourth, baseline data were not available per patient so 
we had to use the healthy standard population as a substitute baseline to compare the HRQoL 
measurement with the test point after the onset of CRPS I. Finally, one of the components of our 
treatment strategies with free radical scavengers and vasodilators has barely been used outside 
of Europe. One could argue that these medical interventions could have been responsible for 
the less favorable outcome described by other studies, but it is questionable that this is very 
likely. Psychological treatment was not part of the standard treatment for children with CRPS 
I before 1995, though on indication by the multidisciplinary team psychological consultation 
was asked before 1995. Further investigations by means of randomized controlled trials should 
be performed to evaluate and validate the effect of scavenger therapy and peripheral vasodila­
tors in children with CRPS I.
In conclusion, while previous publications generally suggests a more favourable prognosis for 
childhood-onset CRPS I, our series showed that at long-term follow-up, a considerable propor­
tion of patients continued to experience moderate pain and they have modest reductions in 
median HRQoL sub scores, compared to the control group. Recurrent episodes are also com­
mon in one-third of cases. Therefore children treated for childhood-onset CRPS I do not have a 
better quality of life as compared to adult-onset CRPS I.
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Background:
The pathophysiology of Complex Regional Pain Syndrome type I (CRPS I) is unclear. An inflam­
matory reaction may cause the syndrome in which leukocytes may play an important role.
Methods:
In this pilot study of six patients with acute warm CRPS I, we performed radiolabeled autolo­
gous leukocyte scans of both hands, in order to assess leukocyte accumulation. Comparison 
was made with the unaffected limb, and with three control patients with a Colles' fracture 
without CRPS I.
Results:
Images of the CRPS I patients obtained 4 hours after leukocyte injection provided the clearest 
results. At 4 hours post-injection, there was clear, asymmetrical leukocyte accumulation in 
the affected extremity with a mean ratio of 1.49 ± 0.19. In control patients, no asymmetry was 
observed between hands (mean ratio 1.09 ± 0.06), indicating the absence of specific leukocyte 
accumulation. There was a statistically significant difference between CRPS I and control sub­
jects 4 hours post injection (p = 0.012).
Conclusion:
We found a significantly increased accumulation of leukocytes in patients with CRPS I. This is 
the first study to show a possible role for leukocytes in the pathophysiology of acute CRPS I.
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Complex Regional Pain Syndrome type I (CRPS I) is a poorly understood syndrome which may 
occur in an extremity after even a minor injury or operation. Although the clinical signs and 
symptoms of CRPS I are well known, the underlying pathophysiology remains unclear. Sudeck 
hypothesized that an excessive inflammatory reaction may cause the syndrome1. Observations 
supporting the inflammatory theory include:
(a) The dominance of clinical signs and symptoms of inflammation - such as unexplained 
severe pain, oedema, a difference in skin temperature, a difference in skin colour - in the 
affected extremity at the onset of CRPS I2,
(b) An increased extravasation of indium-labeled immunoglobulin as a sign of increased capil­
lary permeability for macromolecules3,
(c) A therapeutic response to various oxygen radical scavengers4,
(d) Recently higher levels of IL-6 and TNF-a in blister fluid in the involved extremity in compari­
son to the uninvolved extremity5 and
(e) Successful intervention in a pilot study with anti-TNF6.
In the acute phase, CRPS I is characterized by signs and symptoms of inflammation within the 
affected extremity2. We hypothesized that CRPS I is an exaggerated inflammatory response and 
that the increased capillary permeability can be due to endothelial damage caused by oxygen 
radical species directly or mediated by polymorphonuclear leukocytes.
In this study we performed radiolabeled autologous leukocyte imaging of both hands in 
patients with CRPS I of one upper extremity after a fracture or operation of the hand and com­
pared that with the unaffected contralateral hand. A second control consisted of patients with a 
Colles' fracture who did not develop CRPS I. This control group was chosen considering the high 
incidence of CRPS I after a Colles' fracture (8 - 37%)2,7. Our goal was to asses, in the acute phase 
of CRPS I, accumulation of leukocytes in the affected extremity, which could point to a possible 
role for leukocytes in the pathophysiology of acute CRPS I.
m eth o d s
The study was performed in the out-patient clinic of the Departments of General Surgery, 
Radboud University Nijmegen Medical Centre and the Canisius Wilhelmina Hospital Nijmegen. 
All new patients presenting with signs and symptoms of acute warm CRPS I, after preferably 
a Colles'fracture were invited to participate in the study. Patients with abnormalities in the 
contralateral hand were excluded. The study protocol was approved by the Regional Ethical
in tro d u ct io n
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Committee Arnhem-Nijmegen. Written informed consent was obtained from all patients. The 
following diagnostic criteria were used in making the diagnosis of CRPS I2:
1. Presence of at least 4 of the following 5 signs and symptoms: unexplained diffuse pain and 
tenderness in the distal part of the extremity, difference in skin colour in relation to the 
healthy symmetrical limb, diffuse oedema, difference in skin temperature in relation to the 
healthy symmetrical limb and limited range of movement.
2. The above signs and symptoms increase during exercise.
3. The above signs and symptoms are present in an area much larger than the area of primary 
injury or operation and including the area distal to the primary injury.
All patients were managed according to a standardised treatment protocol8. Skin temperature 
was measured three times at the dorsal surface of the hand, with an infrared (ear) thermometer 
(Generic Sherwood medical First Temp "Genius" Digital Ear Thermometer), held 1 cm above 
the skin surface. The pain was scored according to the visual analogue score (VAS) for pain. 
Approximately 50 ml of blood was drawn from the antecubital vein of the unaffected extrem­
ity. Leukocytes were isolated and labelled with 200 MBq 99mTechnetium- Hexamethylpropyl- 
eneamine oxime (99mTc- HMPAO), as described by Peters et al.9 and re-injected in the cubital 
vein. HMPAO is an efficient leukocyte label, and labels granulocytes with more stability than 
mononuclear leukocytes10,11. After one and 4 hours gamma camera images were acquired from 
both hands using a gamma camera (Orbiter; Siemens Medical Systems, Inc., Hoffman Estate, IL, 
USA). The images were analyzed by drawing regions of interest on both hands. The leukocyte 
accumulation was expressed as the ratio of uptake between the affected and unaffected hand. 
Also the specific leukocyte accumulation at the former fracture site was measured, expressed as 
the ratio of uptake between the fracture site (if present) and the identical contralateral region. 
Statistical analysis was performed using the unpaired samples t-test and the Spearmen rank 
correlation test. Results were considered significant when p < 0.05.
resu lts
Included were four female and two male patients with acute warm CRPS I (mean age 54 years; 
range 42 - 66 years). In 5 patients the left extremity was involved. As shown in Table 1, the mean 
interval between trauma and leukocyte imaging was 71 days (range 35 - 194 days). The mean 
interval between the start of symptoms and leukocyte imaging was 18 days (range 1 - 46 days). 
The mean score on the VAS was 4.7 (range 0 - 10), the mean difference in skin temperature was 
2.6° C (range 0 - 5°C).
The three control patients were all female, with a mean age of 62 years (range 52 - 72 years) 
(Table 1). Leukocyte scans were performed 60 days after the initial trauma. No control patient
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Table 1. CRPS I patient and control patient characteristics, WBC uptake ratio affected versus healthy hand, 4 
hours after injection and WBC uptake ratio specific at the fracture site, 4 hours after injection.
Nr Gender Trauma or operation 4 hrs 4 hrs p.i. Time Time after Time after
Age p.i. fracture after trauma to CRPs i to
(yrs) site trauma to 
CRPs i
scan scan
1 F 66 Dupuytren operation 1.65 No
fracture
42 days 47 days 5 days
2 F 53 Colles' fracture, 5 weeks plaster of 
Paris
1.44 2.85 39 days 44 days 5 days
3 F 66 Colles' fracture, external fixation 1.31 1.44 158 days 194 days 36 days
4 M 45 Metacarpal III and V fracture 
internal fixation with K-wires
1.77 1.52 34 days 35 days 1 day
5 M 42 Colles' fracture and scaphoid 
fracture, internal fixation with plate 
and 12 weeks plaster of Paris
1.27 1.6 41 days 55 days 14 days
6 F 54 Distal antebrachial fracture, 
external fixation
1.49 1.57 6 days 52 days 46 days
7 F 52 Control
Colles' fracture, 5 weeks plaster of 
Paris
1.06 1.74 60 days
8 F 72 Control
Colles' fracture, 6 weeks plaster of 
Paris
1.06 1.56 60 days
9 F 63 Control
Colles' fracture, 6 weeks plaster of 
Paris
1.16 1.88 61 days
p.i. = post injection
had any signs or symptoms indicating CRPS I. All fractures presented with signs and symptoms 
pointing to a normal healing process at the time of measurement and all control patients were 
free of complaints.
The images of CRPS I patients obtained 4 hours after leukocyte injection provided clearest 
results (Figure 1). At 4 hours post-injection, there was clear, asymmetrical leukocyte accumula­
tion in the affected extremity with a mean ratio of 1.49 ± 0.19. In control patients, no asym­
metry was observed between hands (mean ratio 1.09 ± 0.06), indicating the absence of specific 
leukocyte accumulation. There was a statistically significant difference between CRPS I and 
control subjects 4 hours post injection (p = 0.01). In the CRPS I patients, the accumulation in the 
affected extremity showed a negative correlation with the interval between trauma and imag­
ing (r = -0.77) however this was not significant p = 0.07 with the Spearmen rank correlation test 
(Figure 2). In both CRPS I patients and controls, some activity was noted at the former fracture 
site. In the mean ratio of leukocyte accumulation at the former fracture site was similar for CRPS 
I patients and for the controls (1.80 ± 0.59 and 1.73 ± 0.16, respectively, p = 0.74).
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Figure 1. WBC uptake of patient no. 6 , 4 hours after injection. There is a clear, visually asymmetrical 
leukocyte accumulation in the affected right hand. Some activity was noted at the former fracture site 
(arrow), the distal antebrachial fracture.
d isc u ss io n
In this study, we found evidence of increased leukocyte accumulation in acute CRPS I after 
a trauma or operation of the hand. This accumulation seemed to decrease with the interval 
between trauma and imaging; however this was not statistically significant probably due to 
the small numbers. In contrast, some 9 weeks after the Colles' fracture, no specific leukocyte 
targeting was found in control patients without CRPS I. In CRPS I patients, increased leukocyte 
accumulation is most probably due to prolonged extravasation and accumulation of leuko­
cytes which suggests an ongoing inflammatory response, even after the fracture or trauma had 
healed.
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Figure 2. WBC uptake ratio affected versus healthy hand, 4 hours after injection versus time trauma to 
imaging (days).
Leukocytes can be categorized into three main groups: granulocytes, monocytes and lympho­
cytes. Lymphocytes are known to intervene in immune responses such as secreting cytokines, 
killing cells, or the production of antibodies. Monocytes and macrophages participate in inflam­
mation by synthesizing numerous mediators and eliminating various pathogens. The main 
type of granulocytes is the neutrophil, also called the polymorphonuclear leukocyte (PMN)12. 
The PMN or segmented neutrophil is the end-stage of full maturation of the granulocyte. 
This cell type is involved in the pathophysiology of many processes variable from ischemia- 
reperfusion13 to adult respiratory distress syndrome (ARDS), rheumatoid arthritis, inflammatory 
bowel diseases12 and probably also CRPS I. 99mTc- HMPAO has been demonstrated to show a 
preference for granulocytes11. The PMN capability to inflict damage has been credited to its 
ability either to release toxic granule components or to generate reactive oxygen metabolites. 
By oxidatively inactivating a series of key proteinase inhibitors and simultaneously activat­
ing latent proteinases, PMN are able to exert more damage and with greater specificity than 
with oxidants alone14. Aggregation to the endothelium, causing the release of proteases and 
release of oxygen radical species15, and plugging of the microcirculation, causing a no-reflow 
phenomenon can also inflict ischemia-reperfusion induced tissue injury16. Another mechanism 
which could aggravate cellular damage is induction of vascular contraction by inactivation of 
endothelial nitric oxic by PMN-derived oxide, and promotion of release of proinflammatory 
arachidonic acid metabolites13.
The first stage of fracture repair is characterized by extravasation of blood followed by aseptic 
inflammation. The haematoma at the fracture site is invaded by a variety of blood elements 
including polymorphonuclear leukocytes. Although it has been generally accepted that this 
inflammatory response is beneficial, there are reports that PMN may aggravate the tissue dam­
age if inflammatory stimuli are chronically directed against host tissue or are not properly down 
regulated14. Most of the CRPS I and control patients in this study were in the phase of fracture
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repair, which explains the persisting accumulation of granulocytes at the former fracture site 
compared with the normal contralateral hand in both groups. This accumulation at the former 
fracture side diminishes in time.
To our knowledge, this is the first study which directly points to a possible role of leukocytes 
in the acute phase of CRPS I. Currently no histology is available in the acute phase of CRPS I, 
since in the acute phase any additional injury may trigger an increase of severity or recurrence 
of CRPS I.
In an experimental model of acute CRPS I, which uses free radical donor infusion in one extrem­
ity of the rat, vascular permeability and considerable soft tissue damage was induced17. In this 
animal model, we have shown that PMN depletion decreased the increased vascular perme­
ability of the capillaries to some extent. This finding is in agreement with a study describing that 
free radicals are primarily responsible for increased vascular permeability of skeletal muscle in 
ischemia-reperfusion18 and that PMN's induce an additional effect on vascular permeability in 
ischemia-reperfusion19. Both free radical generating capacity and release of proteases by PMN's 
could contribute to the vascular permeability16,20,21. Another explanation for the amplification 
of oxidative stress injury by PMN's may be the adherence of PMN's to endothelial cells, which 
triggers endothelial cells to generate additional free radicals15,20.
One study examined nitric oxide production by peripheral monocytes stimulated with 
interferon-Y (IFN-y) in CRPS I patients. Although no differences were found between the 
samples taken from the contralateral and ipsilateral extremity, a significant increase in absolute 
NO release in response to IFN-y was present compared to controls20,22.
Further research should be conducted, focused on the function of leukocytes at the direct site 
of CRPS I.
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Background:
In the chronic constriction injury (CCI) model of rat neuropathic pain, oxidative stress as well as 
the antioxidants superoxide dismutase and reduced glutathione are important determinants 
of neuropathological and behavioural changes. Studies in the CCI model observed (indirect) 
signs of inflammation. We, therefore, investigated the level of oxidative stress and antioxidant 
enzymes in skeletal muscle tissue of the rat hind paw and (jugular vein) plasma at day 7 after 
nerve-injury.
Methods:
The level of reactive oxygen and nitrogen species (RONS) was determined as a measure of 
oxidative stress. Reduced glutathione (GSH) levels and the ceruloplasmin/transferrin ratio were 
determined as measures of overall antioxidant activity. RONS and overall antioxidant activity 
were measured in skeletal muscle tissue of the hind paw and jugular vein plasma. The level of 
RONS in muscle was determined using spin trapping combined with electron paramagnetic 
resonance spectroscopy. Using electron paramagnetic resonance spectroscopy, we also deter­
mined plasma levels of transferin and ceruloplasmin. Glutathione (GSH) levels were determined 
using high-performance liquid chromatography.
Results:
In skeletal muscle tissue, the level of RONS was lower in nerve-injured hind paws than in con­
trols. The plasma level of RONS did not differ between nerve-injured and control rats. In skeletal 
muscle tissue, the level of GSH was higher in nerve-injured hind paws than in controls. The 
ceruloplasmin/transferrin ratio tended to be higher in (jugular vein) plasma of nerve-injured 
rats as compared to controls.
Conclusion:
This study shows that, at day 7 after nerve-injury, oxidative stress-induced changes are pres­
ent in skeletal muscle tissue of the rat hind paw. Our findings of a decreased level of RONS 
in combination with an increased level of the antioxidant GSH suggest that an overshoot of 
antioxidant activity overrules initial oxidative stress.
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Oxidative stress may cause cell damage through increased oxidant generation, decreased 
antioxidant protection, and/or failure to repair oxidative damage. Cell damage is induced by 
reactive oxygen and nitrogen species (RONS), which are either free radicals, reactive anions 
containing oxygen atoms or molecules containing oxygen atoms that can either produce free 
radicals or chemically activated by them. Under normal conditions, RONS are cleared from 
cells by the action of superoxide dismutase, catalase or glutathione, as well as the antioxidant 
vitamins C and E. In pathological conditions, however, intracellular RONS level can cause severe 
cell damage and even cell death.
In the chronic constriction injury (CCI) model of rat neuropathic pain, it has been shown that 
oxidative stress as well as antioxidants superoxide dismutase and reduced glutathione are 
important determinants of neuropathological and behavioural consequences1. Heat hyper­
algesia is reduced by systemically injected antioxidants2,3. Likewise, systemic injection of the 
reactive oxygen species scavenger phenyl-W-ferf-butylnitrone relieves mechanical allodynia in 
the spinal nerve ligation (SNL) model of neuropathic pain4. In the CCI model, the role of oxida­
tive stress has been investigated and confirmed only in neural structures, more specifically in 
the injured sciatic nerve and spinal cord. However, one should realize that other studies in the 
CCI model observed (indirect) signs of inflammation also in non-neural tissues. Among these 
are increased skin blood flow and skin temperature at an early stage after nerve injury5 as well 
as oedema and increased extravasation of polymorphonuclear leukocytes in skeletal muscle 
tissue6. These inflammatory changes may also involve oxidative stress. We, therefore, investi­
gated the level of oxidative stress and antioxidant enzymes in skeletal muscle tissue obtained 
from the nerve-injured hind paw and in jugular vein plasma at day 7 after nerve-injury. 
Measurement of free radical concentrations is difficult, because they are extremely short lived 
and only produced in minute quantities. Assessing the level of radicals is generally performed 
by indirect methods such as the determination of the level of xanthine oxidase, which catalyzes 
the formation of superoxide, and the effect of antioxidant treatment on levels of lipid hydro­
peroxides (products of lipid peroxidation caused by free radicals)7. Transferrin is an iron binding 
protein, which prevents free iron to form toxic quantities of free radicals, thus having important 
antioxidant qualities. Ceruloplasmin also is an important antioxidant. Both are important extra 
cellular endogenous antioxidants. Transferrin and ceruloplasmin were determined as measures 
of antioxidant activity (AOA) in plasma. Glutathione (g-glutamyl-cysteinylglycine) is a sulfhy- 
dryl (-SH) antioxidant, antitoxin, and enzyme cofactor. The antioxidant "reduced glutathione" 
tripeptide is conventionally called glutathione (GSH). We assessed the level of transferrin, 
ceruloplasmin and glutathione as measures of oxidative stress.
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Animals
We used adult male Sprague-Dawley (Animal Research Laboratories, Himberg, Vienna, Austria) 
rats weighing 300 to 400 gram (mean 372 gram). The animals were granted free access to 
standard laboratory chow and water during a 7-day adaptation period after delivery to our 
experimental unit. All animals were maintained in a room at 22°C with a 12-h light-dark cycle. 
Prior to the experiment, the rats were fasted overnight with free access to water. The protocol 
of the study was approved by the Animal Protocol Review Board of Vienna and followed the 
requirements defined in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health (publication NIH 86-23, revised 1985).
Surgical procedure
The rats were anaesthetized by intra peritoneal injection of ketamine 70-mg/kg body weight 
and xylazine 10-mg/kg body weight subcutaneously. The animals were kept on a temperature- 
controlled surgical board (38 ± 1°C) and allowed to breathe spontaneously. Animals were 
divided into two groups; neuropathic (n = 9) and controls (n = 9). Rats of the control group 
were not subjected to any kind of surgery. In the neuropathic group the common left sciatic 
nerve was exposed at the level of the middle thigh by blunt dissection through the biceps 
femoris, using a microscope with 40x magnification. Proximal to the sciatic nerve trifurcation, 
about 7 mm of nerve was freed of adhering tissue and 4 ligatures (4/0 catgut, Ethicon, Johnson 
& Johnson, Brussels, Belgium) were tied loosely around it with about 1 mm spacing (Figure 1). 
The length of nerve thus affected was 4 - 5 mm long. The ligatures were tied in a way that the 
nerve was just barely constricted. The incision was closed in layers with catgut 4/0 (Ethicon), the 
skin with mersilene 2/0 (Ethicon).
Sampling of plasma and skeletal muscle tissue
On the day of surgery as well as before instrumentation for trap application on day seven, 
clinical signs and symptoms were assessed as described in detail previously8. To determine the 
oxidative status on day seven after nerve-injury, the rats were anaesthetized and maintained 
under anaesthesia by a mixture of 0.8%  isoflurane and room air for the duration of the opera­
tion. The animals were kept on a temperature-controlled surgical board (38 ± 1°C) and allowed 
to breathe spontaneously. Following the induction of anaesthesia, the jugular vein was cath- 
eterised under aseptic conditions with a polyethylene catheter (PE50, Clay Adams, Parsipany 
NJ) filled with heparinised Ringer's solution (8 units/mL). A first heparinised blood sample 
(1.5 mL) was withdrawn, and blood volume replaced by 1.5 mL Ringer's solution. Plasma was 
separated by centrifugation during 10 minutes at 3000 g (12.000 rpm at 6°C). Subsequently, the 
spin trap 1-hydroxy-3-carboxy-pyrrolidine (CPH), developed to detect superoxide radicals and 
peroxinitrite radicals (RONS), was intravenously administrated in five animals in each group9.
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Figure 1. The chronic constriction injury (CCI) model of rat neuropathic pain; proximal to the sciatic nerve 
trifurcation, about 7 mm of nerve was freed of adhering tissue and 1 ligature (4/0 catgut, Ethicon, Johnson 
& Johnson, Brussels, Belgium) is tied loosely around (in total 4 ligatures with about 1 mm spacing will be 
placed).
At the end of the CPH infusion period of 30 minutes, tissue samples were obtained of the left 
gastrocnemius muscle. In animals without CPH infusion (n = 4), gastrocnemius muscle samples 
were collected by freeze clamping, and directly frozen in liquid nitrogen for GSH analysis in 
duplicate.
Clinical signs and symptoms
On both hind paws, a mark was placed above the ankle joint to perform identically localized 
measurements. Skin temperature was measured on the plantar area of both hind paws using a 
surface electrode (diameter = 0.6 cm; Keith, Geneva, Ohio, USA) and the temperature difference 
between both paws was noted. The circumference of the paw was measured using a string. The 
function of the left hindlimb was observed in a perspex cage 26 x 26 x 26 cm after 5 minutes 
habituation. During 5 minutes the time of different position of the operated paw was noted 
according to the spontaneous pain scale of Attal10. The neutral position is the position when 
the operated paw is posed normally on the floor of the cage. The position is not neutral if the 
paw rests lightly on the floor with the toes in plantar flexion, or only partially (with the heel or
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the internal edge of the paw) or is completely elevated. Walking function was assessed during 5 
minutes. If necessary, the rat was stimulated to walk. The walking function was noted as impaired 
when the rat showed a shuffling gait. Grasping function was assessed by letting the rat grasp 
the edge of the perspex cage 5 times. Grasping function was impaired if no grasping occurred.
Mechanically and thermally induced pain reflexes were assessed. Mechanical sensitivity was 
tested by foot withdrawal in response to mechanical stimulation with Von Frey filaments (North 
Coast Medical, San José, USA) of two bending forces (5.16 gram and 12.5 gram). The rats were 
placed in a perspex cage with a wire mesh floor (26 x 26 x 26 cm). After 5 minutes accommoda­
tion, a Von Frey filament was applied 10 times (once every 5 seconds) to the plantar surface of 
both hind paws and the frequency of foot withdrawal was noted11. Thermal pain was measured 
on a heated floor of 40 ± 1°C. After 5 minutes of accommodation the pain was scored according 
to the spontaneous pain score of Attal10.
Determination of level of RONS, ceruloplasmin, and transferrin
Heparin plasma was used for electron paramagnetic resonance (EPR) analysis12,13. Three hun­
dred fifty |jL of plasma was placed in a 1 mL syringe and immediately frozen in liquid nitrogen. 
Then, the sample was pressed out of the syringe and moved to a fingertip liquid nitrogen Dewar 
for electron paramagnetic resonance (EPR) analysis. The EPR spectra of RONS (CPH-adducts) 
were recorded at liquid nitrogen temperature as described in detail previously12,13 using a 
Bruker EMX EPR spectrometer at the following setting: microwave frequency 9.431 GHz, modu­
lation frequency 100 kHz, microwave power 31 mW, modulation amplitude 15 G; gain 105). The 
double integrals of transferrin (g-factor 4.31) and ceruloplasmin (g-factor 2.05) signals were 
calculated and compared with those obtained from standard iron (III) and Cu (II) complexes. The 
standard iron (complexes were prepared by mixing 10 millimol desferrioxamine B with different 
amounts of iron ions (FeSO4 x 7H2O). Desferrioxamine iron complex formed in this mixture was 
used as a standard. Standard Cu (II) solutions were prepared by adding different amounts of 
copper ions (CuSO4 x 5 H2O) to 10 millimol diethyldithiocarbamate (DETC) solved in 10% Bovine 
serum albumin. Copper DETC complex formed in this mixture was used as a standard. The final 
iron/copper concentrations were ranging from 0 to 25 |jM. Upon reaction with RONS CP-H is 
transformed into a stable CP^  radical (3-carboxy-proxyl). Standard solutions of 3-carboxy-proxyl 
were used to quantify RONS levels in plasma and skeletal muscle tissue.
Determination of level of glutathione in skeletal muscle tissue
Tissue samples, frozen in liquid nitrogen, were homogenized in 0.4 M HClO4 using a ball mill. 
After centrifugation acid extracts were stored at -20°C or analyzed immediately by means of 
ion-pair reversed-phase high-performance liquid chromatography (HPLC) with electrochemi­
cal detection. The HPLC-System included a Spherisorb S3ODS-2 column (3 |jm, 125 mm x 4 mm 
ID; Phenomenex, Torrance, CA), a Rheodyne 7125 injector (Rheodyne, Cotati, CA), a PU-980
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HPLC pump (Jasco, Great Dunmow, United Kingdome), a pulsation dampener (Shodex, Tokyo, 
Japan), a Coulochem 5100 A electrochemical detector (ESA, Bedford, MA) equipped with a 5011 
analytical cell (+ 0.4 V). Data acquisition and analysis was done with an analog interface AI 406 
and System Gold software (both Beckman Coulter, Fullerton, CA). The mobile phase consisted 
of 0.1 mol/L sodium acetate, 0.1 mol/L sodium hydrogen phosphate, 400 mg/L sodium dodecyl 
sulfate adjusted to pH 2.0, and 2.5% acetonitrile (vol/vol). Calibration curves for reduced gluta­
thione (GSH) were established daily. Oxidized glutathione (GSSG) was measured after enzymatic 
reduction with the following assay: 100 |jL acid extract were incubated with 50 |jL 2.5 millimol 
N-Ethylmaleinimid (NEM) and 760 |jL 0.1 M phosphate buffer pH 7.0 to mask endogenous GSH. 
Excess of NEM was exhausted with 50 |jL 3mM Sodium 2-mercaptoethanesulfonate. GSSG was 
reduced to GSH by addition of 20 |jL 2 mM NADPH and 20 |jL 12 units Glutathione reductase 
and GSH was measured by HPLC. Glutathione levels were corrected for skeletal muscle wet 
weight and protein content in order to prevent a potential effect of the amount of skeletal 
muscle oedema.
Histology
Parts of the gastrocnemius muscles were quickly frozen in isopentane cooled to -120°C by 
liquid nitrogen. Sections (thickness 10 micron) were cut in a cryostat (at - 20°C) and stained 
with hematoxylin and phloxine.
Additional sections were stained according to standard enzyme histochemical methods for 
myofibrilar ATPase (for fiber typing), and for succinic dehydrogenase (SDH) and cytochrome 
oxidase (COX) to show mitochondrial activity. The main chemicals for the enzyme histochemi­
cal methods were purchased from Roche, Germany (ATP) and Sigma, Germany [nitro blue tet- 
razolium and diaminobenzidine for the SDH and COX stain respectively]; succinate used for 
the SDH method is a general purpose reagent. The middle remaining parts of the left and 
right gastrocnemius muscles were immediately fixed in toto by immersion in cold phosphate- 
buffered paraformaldehyde 4%, pH 7.3. From proximal to distal, 4 transversal slices were taken, 
dehydrated and embedded in Paraplast. Sections of 5 micron in thickness were stained with 
hematoxylin and eosin (HE). In these sections skeletal muscle fibers, blood vessels, and sur­
rounding tissues were light microscopically examined on the presence of structural changes.
Statistical analysis
All data were analyzed using SPSS (Statistical Package for the Social Sciences version 11.0 for 
Windows; SPSS Inc., Chicago, IL). and are expressed as median with standard errors of the mean. 
Statistical analysis was done using the Mann-Whitney U test for unpaired and the Wilcoxon 
signed rank test for paired samples. Statistical significance was considered when p < 0.05.
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resu lts
After 1 - 2 days, rats developed an abnormal gait and posture, guarding behaviour and sudden 
licking of the neuropathic hind paw (NP). Skin temperature difference between the plantar side 
of the NP and the control paw (CP) was -0.06 ± 0.1°C before the operation, increasing to 1.3 ± 
0.4°C after 7 days, which was significant according to the nonparametric (2 related samples) 
Wilcoxon signed rank test (p = 0.008).
The percentage increase of the NP circumference was 4.3 ± 1.7% (p = 0.011). Redness of the 
plantar side of the NP was obvious in 56% of the rats as compared to the CP. An impaired 
walking and grasping function was observed in 89% of the NP's. All operated rats developed 
a claw position of the NP. Pain observation scores were obtained pre-operatively and after 7 
days. Comparison of the pain scores was performed by calculating the difference between the 
pre-operative and postoperative values by the nonparametric Wilcoxon (2 related samples) 
signed rank test. Before the surgical intervention, mechanical stimulation (n = 8) with von Frey 
filament showed negligible withdrawal reactions. Mechanical stimulation with a 5.16 g filament 
resulted in a withdrawal percentage of 0%  pre-operatively, and of 2.2 ± 2.2%  seven days after 
the operation (p = 0.317). Mechanical stimulation with a 12.5 g von Frey filament resulted in a 
significantly increased withdrawal percentage of 0% pre-operatively to 17 ± 5.5% (p = 0.027). 
Pre-operative observation of the rats on the heated plate showed normal behaviour, with a 
heat pain score of 0.06 ± 0%. Seven days after the operation the heat pain score difference 
increased to 0.97 ± 0.1%, which was significant according to the nonparametric (2 related 
samples) Wilcoxon signed rank test (p = 0.011). See Table 1 for all clinical data.
Clinical signs and symptoms
Table 1. Clinical signs and symptoms (data are presented as mean and standard error of the mean).
Parameter Neuropathic animals 
pre-operative
neuropathic animals 
day 7 post-operative
p-value
Skin temperature (°C) -0.06 ± 0.1 (°C) 1.3 ± 0.4 (°C) 0.008
difference left-right foot
Circumference 2.31 ± 0.08 (cm) 2.41 ± 0.06 (cm) 0.011
Colour difference 0% 56% 0.025
Impaired function left paw 0% 89% 0.005
in (%) of the rats observed
Mechanical pain 0.224 ± 0.04 2.2 ± 2,2 0.317
5,16 g filament
Mechanical pain 0 ± 0.04 17 ± 5.5 0.027
12,5 g filament
Heated pain 0.06 ± 0 0.97 ± 01 0.011
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Table 2. Plasma (jugular vein) concentrations of reactive oxygen nitrogen species (RONS), transferrin, 
ceruloplasmin, and antioxidant activity (AOA) in nerve-injured rats and controls (data are presented as 
mean and standard error of the mean).
Parameter neuropathic animals Control animals p-value
RONS [nmol/cm3 plasma] 5.19 ± 0.47 (n = 5) 4.70 ± 0.18 (n = 3) 0.66 
Transferrin (|jM Fe (III)) 25.21 ± 2.74 (n = 8) 25.82 ± 2.09 (n = 7) 0.73 
Ceruloplasmin (|jM Cu(II)) 6.20 ± 0.64 (n = 8) 4.57 ± 0.51 (n = 7) 0.083 
AOA (Cp/Tr ratio)_____________________ 0.224 ± 0.04 (n = 8)___________ 0.148 ± 0.02 (n = 7)_______ 0.15
Table 3. Muscle tissue concentrations of reactive oxygen nitrogen species (RONS) and glutathione (GSH) in 
nerve-injured rats and controls (data are presented as mean and standard error of the mean).
Parameter neuropathic animals Control animals p-value
RONS [nmole/cm3 tissue] 2.80 ± 0.46 (n = 5)* 5.49 ± 0.78 (n = 3) 0.025
GSH [U/mg protein] 8.81 ± 0.32 (n = 3) * 5.72 ± 0.35 (n = 4) 0.034
= p < 0.05
Neuropathic Control
Figure 2. Muscle tissue concentrations of reactive oxygen nitrogen species (RONS) in nerve-injured rats 
and controls (data are presented as mean and standard error of the mean).
* = p < 0.05
Levels of RONS, ceruloplasmin, and transferrin
The levels of RONS, ceruloplasmin, and transferrin in both nerve-injured and control rats are 
presented in detail in Table 2. In skeletal muscle tissue, RONS levels were lower (2.80 ± 0.46 vs. 
5.49 ± 0.78, p < 0.05) in nerve-injured paws (n = 5) than in controls (n = 3) (Table 3 and Figure 2). 
Jugular vein plasma levels of RONS did not differ (5.19 ± 0.47 vs. 4.70 ± 0.18, p = NS) between 
nerve-injured rats (n = 5) and controls (n = 3).
Jugular vein plasma levels of ceruloplasmin tended to be higher (6.20 ± 0.64 vs. 4.57 ± 0.51, p = 
0.083) in nerve-injured rats (n = 8) than in controls (n = 7). Jugular vein plasma levels of transfer­
rin did not differ (25.21 ± 2.74 vs. 25.82 ± 2.09, p = NS) between nerve-injured rats (n = 8) and 
controls (n = 7). Consequently, the ceruloplasmin/transferrin ratio in plasma tended to be higher 
(0.224 ± 0.04 vs. 0.148 ± 0.02, p = 0.083) in nerve-injured rats (n = 8) than in controls (n = 7).
*
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Neuropathic Control
Figure 3. Muscle tissue concentrations of glutathione (GSH) in nerve-injured rats and controls (data are 
presented as mean and standard error of the mean).
*  S ì
figure 4. Rat leg muscle. The 2 arrows point to 2 abnormally large whorled muscle fibers. In these fibers a 
circular splitting line partly bordered by nuclei (dark) is recognizable (Hematoxylin-Phloxine stain, bar: 50 
micron).
Levels of glutathione in skeletal muscle tissue
In skeletal muscle tissue, tissue reduced glutathione levels were higher (8.81 ± 0.32 vs. 5.72 ± 
0.32, p = 0.034) in nerve-injured paws (n = 3) than in controls (n = 4) (Table 3 and Figure 3).
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Histology
Histological analysis of skeletal muscle distally of the nerve constriction, showed no damage on 
a standard HE staining, but sections from frozen skeletal muscle locally revealed some whorled 
fibers suggestive (Figure 4) of regeneration of skeletal muscle14. Control contralateral muscles 
were normal.
d ìsc u ss ìo n
This study in the chronic constriction injury (CCI) model of rat neuropathic pain demonstrates 
that the level of oxidative stress in skeletal muscle tissue of nerve injured hind paws, as indi­
cated by the level of RONS, is decreased at day 7 after nerve injury. In contrast, (antioxidant) 
glutathione levels in skeletal muscle tissue of these rats are increased at this time-point. These 
findings indicate that in the CCI model, oxidative stress-induced changes are present not only 
in the injured sciatic nerve but also in skeletal muscle tissue of the ipsilateral hind paw. Our 
findings of a decreased level of RONS in combination with an increased level of the antioxidant 
glutathione suggest that a surplus of antioxidant activity prevails initial oxidative stress.
The plasma level (jugular vein) of RONS did not differ between nerve-injured and control rats 
indicating that the decrease of RONS in skeletal muscle tissue of CCI rats results from local 
changes in the nerve-injured hind paw rather than from systemic changes. The ceruloplasmin/ 
transferrin ratio in plasma (jugular vein), reflecting systemic antioxidant activity, tended to be 
higher in the neuropathic group than in controls. This tendency towards an increased ratio is 
caused by the fact that ceruloplasmin levels were higher in nerve-injured rats whereas trans­
ferrin levels did not differ between groups. Since ceruloplasmin is an acute phase protein, its 
increase most likely merely results from the surgical procedure one week earlier. The oxidative 
stress induced changes observed in our study suggest that the inflammatory changes observed 
in muscle tissue by others15 also result from oxidative stress.
As alluded to before, Tal et al.2 observed an increased level of RONS in the nerve-injured hind 
paw, more specifically at the site of nerve injury. In contrast, we observed a decrease in the level 
of RONS in skeletal muscle tissue of nerve-injured hind paws. This dissimilarity may result from 
the fact that in our study, tissue specimens were obtained from non-traumatized muscle distal 
to the site of ligation, whereas in Tal's study RONS levels were determined at the site of nerve 
ligation. Alternatively, this difference may result from differences between tissues, i.e., nerve 
and muscle, in the level of antioxidant response to oxidative stress. Our observation that oxida­
tive stress and antioxidant activity are involved in the pathophysiologic mechanisms underly­
ing signs and symptoms in the CCI model is in line with studies showing that antioxidants have 
a beneficial effect on neuropathic pain2,4.
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Low dose ketamine has been reported to have anti-inflammatory effects, with a maximum 
effect at a sub-anaesthetic dose of 10 mg/kg. This anti-inflammatory effect of ketamine weans 
of with increasing dose; since all rats received a high dose ketamine (70 mg/kg), it is unlikely 
that this factor has influenced the outcome of our study16.
In conclusion, our study in CCI rats shows that oxidative stress-induced changes are present not 
only in the injured sciatic nerve but also in skeletal muscle tissue of the ipsilateral hind paw. Our 
findings of a decreased level of RONS in combination with a marked elevation of antioxidant 
enzymes in skeletal muscle and plasma suggest that a surplus of antioxidant activity prevails 
initial oxidative stress.
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a bstra c t
Background:
To investigate oxidative stress and oxygen extraction mechanisms in an animal model of con­
tinuous intra-arterial infusion of a free radical donor, and in an in vitro model using isolated 
mitochondria.
Methods:
Tertbutyl-hydroperoxide (Tert-BuOOH, 25 mM) was infused for 24 hrs in the left hind limb of 
rats to induce soft tissue damage (n = 8). After seven days we assessed local sensory response, 
tissue oxygen consumption, oxygen radicals and antioxidant levels. In vitro mitochondrial 
function was measured after stimulation of isolated mitochondria of skeletal muscle cells with 
increasing doses of Tert-BuOOH.
Results:
Tert-BuOOH infusion resulted in an increased skin temperature (p = 0.04), impaired function 
and a significantly increased pain sensation (p = 0.03). Venous oxygen saturation levels (p = 
0.01) and the antioxidant ceruloplasmin (p = 0.04) were increased. Tert-BuOOH inhibited mito­
chondrial function in vitro.
Conclusion:
Induction of free radical formation in the rat hind limb results in an exacerbated sensory 
response and is associated with impaired oxygen-extraction, which likely results from mito­
chondrial dysfunction caused by free radicals.
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in tro d u ct io n
Pain after limb injury gradually disappears within days to weeks. There are however some 
patients, in which pain remains and becomes chronic as part of the Complex Regional Pain Syn­
drome type I (CRPS I), formerly known as reflex sympathetic dystrophy or Sudecks dystrophy. It 
is a painful, potentially disabling syndrome that usually affects the distal part of the extremity. 
The disorder is characterized by a variety of autonomic and vasomotor disturbances, of which 
diffuse pain, spreading oedema, temperature disturbances, colour changes and functional 
impairment are most prominent1,2. There are various theories on the pathophysiology of this 
process3. Amongst these are immunologic alterations, changes in plasticity of the sympathetic 
and central nervous system, and neurogenic inflammation. Neurogenic inflammation is caused 
by mechanical and/or chemical activation of sensory neurons and/or small diameter sensory 
nerve fibers. As a result, inflammatory mediators such as substance P and calcitonin gene- 
related peptide are released from the distal endings of these sensory nerves causing vasodilata­
tion, plasma extravasation, and hypersensitivity. Various studies have demonstrated that local 
release of these neuropeptides induces oxidative stress reflected by an excessive production of 
reactive oxygen and nitrogen species (RONS)4,5. RONS have been associated with neuropathic 
pain and the development of chronic pain such as in CRPS I6, but the mechanism of action of 
RONS involved in the development of pain and the underlying mechanisms are not yet fully 
understood7,8. Recently, we have studied specific RONS-related pathophysiological changes in 
a chronic constriction injury rat model of neuropathic pain by means of recently developed 
spin-trap and electron paramagnetic resonance spectroscopy (EPR) techniques9. It was found 
that oxidative stress-induced changes are present not only in the injured sciatic nerve but also 
in skeletal muscle tissue. Drawback of the chronic constriction injury model is that it resembles 
CRPS type II (nerve injury present) and not CRPS type I10.
It has been suggested that RONS play a role in the pathophysiology of CRPS I through impaired 
oxygen extraction similar to conditions like the adult respiratory distress syndrome (ARDS), 
the systemic inflammatory response syndrome (SIRS) and multi organ dysfunction syndrome 
(MODS)11-14. High mixed venous oxygen saturations and elevated lactate levels at rest are 
characteristic of a condition with impaired oxygen extraction as it reflects the inability of tissue 
or muscle to utilize oxygen despite sufficient supply11.
Aim of this study was to investigate oxidative stress, as measured by RONS and antioxidant 
levels, and oxygen extraction, as measured by blood gas analysis, in a known animal model 
of free radical induced soft tissue injury without inducing ischemia, mimicking clinical signs 
of CRPS I15,16. Second aim was to relate oxygen extraction to mitochondrial function. This was 
done by using an in vitro model of isolated skeletal muscle mitochondria that were subjected 
to Tert-BuOOH17.
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ex per im en t a l  procedures
Animals
Sixteen adult male Sprague-Dawley rats (Animal Research Laboratories, Himberg, Vienna, 
Austria) weighing 350 to 400 gram and eight adult male Sprague-Dawley rats (Animal Research 
Laboratories, Himberg, Vienna, Austria) weighing between 260 to 300 gram were used for in 
vivo and in vitro experiments, respectively. The animals were granted free access to standard 
laboratory chow and water during a 7-day adaptation period after delivery to our experimental 
unit. All animals were housed at 22°C with a 12-h light-dark cycle. Prior to the experiment, the 
rats were fasted overnight with free access to water. The protocol of the study was approved 
by the animal protocol review board of Vienna and followed the requirements defined in the 
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (publica­
tion NIH 86-23, revised 1985).
Study design
Rats underwent a 24-hour arterial infusion of Tert-BuOOH into the hind limb, inducing free 
radical associated soft tissue damage. At day seven anaesthetized experimental (Tert-BuOOH 
infused) and control rats (no infusion) received catheters in the jugular veins for blood sampling 
to assess oxygen radicals and the antioxidants ceruloplasmin and transferrin. Both femoral 
veins were punctured in the experimental animals for blood gas analysis. Thereafter all rats 
were killed and biopsies were taken from the gastrocnemius muscle to determine RONS and 
glutathione. Throughout the experimental period rats were observed daily for (pain) behaviour. 
Skin temperature, hind limb circumference and mechanical and heat pain responses were 
measured at day 1 before Tert-BuOOH infusion and at day 7 before anaesthesia.
Surgical procedures
At day one, eight randomly assigned rats were anaesthetized by intraperitoneal injection of 
ketamine 70-mg/kg body weight and subcutaneous injection of xylazine 10-mg/kg body 
weight. The animals were kept on a temperature-controlled surgical board (38 ± 1°C) and 
allowed to breathe spontaneously. The rats in the infusion group (n = 8) were anticoagulated 
intravenously with 100 units/kg heparin sodium. A polythene cannula (i.d. 0.28 mm; o.d. 0.61 
mm, Laboratoire Portex, France) was placed retrogradely in the left superficial epigastric artery. 
The tip of the catheter was positioned at the junction of the superficial epigastric artery and 
common femoral artery, thus preventing impairment of arterial blood flow to the hind limb. 
The catheter was fixed with polyester sutures 6/0 (Dagrofil, Braun, Melsungen, Germany) and 
sealed with glue (Histoacryl, Braun, Melsungen, Germany). The other end of the cannula was 
tunnelled subcutaneously over the back of the rat to its head and connected to a flexible 
stainless swivel system. The swivel was connected to an infusion system. The rats were then 
awaked and placed in a specially equipped box being able to walk freely in the cage with the
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Figure 1. Infusion model in which the left superficial epigastric artery is cannulated. The other end of 
the cannula is tunnelled subcutaneously over the back of the rat to its head and connected to a flexible 
stainless swivel system. The swivel was connected to an infusion system. The rat is than placed in a specially 
equipped box, and able to walk freely in the cage (photo courtesy of L. van der Laan).
possibility of intra-arterial infusion in the hind limb without compromising blood flow (Figure
1). After cannulation, infusion was started immediately. During 24 hrs, the rats were infused 
with Tert-BuOOH (Sigma, St. Louis, USA) dissolved in saline to a final concentration of 25 mM 
(pH 6 .8) with heparin (2,5 U/mL) , in a final dose of 0.6 mmol. Infusion of Tert-BuOOH leads to 
free radical formation and free radical induced soft tissue damage15,18-20. After 24 hrs the infu­
sion system was disconnected. All rats were monitored daily for spontaneous pain and other 
abnormal behaviour.
At day 7 experimental rats (n = 8) and control rats (n = 8) were anaesthetized by a mixture of
0.8% isoflurane and room air for the duration of the procedure. The animals were kept on a 
temperature-controlled surgical board (38 ± 1°C) and allowed to breathe spontaneously. Fol­
lowing induction of anaesthesia, the jugular vein was catheterised under aseptic conditions 
with a polyethylene catheter (PE50, Clay Adams, Parsippany, NJ., USA) filled with heparinised 
Ringer's solution (8 units/mL). A first heparinised blood sample (1.5 mL) was collected for 
measurements of antioxidants, and blood volume was replaced by 1.5 mL Ringer's solution. 
Subsequently, the spin trap 1-hydroxy-3-carboxy-pyrrolidine (CPH), detecting superoxide 
radicals and peroxynitrite radicals (RONS), was intravenously administered in five experimental 
and five control animals21. At the end of the 30 minutes CPH infusion period, blood samples (1.5 
mL) from the jugular vein were collected again for measurement of RONS. Blood samples were
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also drawn by direct puncture of both femoral veins (2 x 0.5 mL) in experimental rats for blood 
gas analysis. Thereafter, all animals were killed and a piece of the left (infused) and left (controls) 
and right (infused contralateral) gastrocnemius muscle was excised and immediately frozen in 
liquid nitrogen for RONS and glutathione analysis.
Skin temperature, limb circumference, pain behaviour and evoked pain responses
Skin temperature was measured on the plantar side of both hind paws using a surface electrode 
(diameter = 0.6 cm; Keith, Geneva, Ohio, USA). The circumference of the hind paw just above 
the ankle was measured using a string. The relative change of the volume of the operated hind 
limb to the preoperative situation served as a parameter for contour alterations. Colour of the 
left plantar foot was observed and compared to that of the right foot. The neutral position, 
grasp, and walking function of both hind paws were recorded by observation of each rat for 
5 minutes. The function of the left hind limb was noted as impaired when the rat had either a 
clench paw, did not show grasping or showed a shuffling gait, respectively. Observation of pain 
signs was performed preoperatively, and after 7 days after disconnection from the infusion 
system. Three different pain forms were assessed according to tests performed in the classi­
cal neuropathic pain22 or peripheral inflammation23,24 model in the rat: spontaneous pain, 
mechanically induced pain, and thermally induced pain. Spontaneous pain behaviour of rats 
was observed in a perspex cage of 26 x 26 x 26 cm after a 5-min habituation. The time of differ­
ent positions of the lesioned paw was noted, according to the scale of Attal et al.25 which varied 
from 0 (the operated paw is pressed normally on the floor) to 5 (the animal licks the operated 
paw). The spontaneous pain was calculated by the formula t1 + 2t2 + 3t3 + 4t4 + 5fs/300 sec, 
where t1, t2, t3, t4, and t5 are the times (in sec) spent in categories 1, 2, 3, 4, or 5, respectively. 
Mechanical sensitivity was tested by foot withdrawal in response to mechanical stimulation 
with Von Frey filaments (North Coast Medical, San José, USA) of two bending forces (5.16 g and
12.5 g). To this end, the rats were placed in a perspex cage with a wire mesh floor (26 x 26 x 26 
cm). After 5 minutes accommodation, a Von Frey filament was applied 10 times (once every 
5 seconds) to the plantar surface of the paw during which the frequency of foot withdrawals 
was noted26. Thermally induced pain was assessed on a heated floor of 40 ± 1°C. Following 5 
minutes accommodation, the level of thermally induced pain was scored following the next 
5 minutes according to the pain score of Attal et al.25. For example, if the operated paw was 
pressed normally on the floor during 5 minutes (300 seconds), this was scored as 0, the rat was 
not in pain. If the rat demonstrated constant licking of his operated paw, this was scored as 
5x300/300 = 5.
Blood gas analysis
Blood gas analysis including oxygen tension (pO2), pH, oxygen saturation (SvO2), and lactate 
level was done in heparinised femoral vein blood samples immediately after bilateral puncture, 
using a Radiometer ABL 625 Blood Gas Analyzer (Copenhagen, Denmark).
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Determination of level of RONS, ceruloplasmin and transferrin in plasma
Plasma of jugular vein heparinised blood samples was separated by centrifugation during 10 
minutes at 3000 g (12.000 rpm at 6°C). Heparin plasma was used for electron paramagnetic 
resonance (EPR) analysis27,28. Three hundred fifty |jL of plasma was put in a 1 mL syringe and 
immediately frozen in liquid nitrogen. The sample was then pressed out of the syringe and put 
in a liquid nitrogen Dewar for electron paramagnetic resonance (EPR) analysis. The EPR spectra 
of RONS (CPH-adducts) were assessed at liquid nitrogen temperature as described in detail pre­
viously27,28 using a Bruker EMX EPR spectrometer at the following setting: microwave frequency 
9.431 GHz, modulation frequency 100 kHz, microwave power 31 mW, modulation amplitude 15 
G; gain 105. The double integrals of transferrin (g-factor 4.31) and ceruloplasmin (g-factor 2.05) 
signals were calculated and compared with those obtained from standard iron (III) and Cu (II) 
complexes. The standard iron complexes were prepared by mixing 10 millimol desferrioxamine 
B with different amounts of iron ions (FeSO4 x 7H2O). Desferrioxamine iron complex formed 
in this mixture was used as standard. Standard Cu (II) solutions were prepared by adding dif­
ferent amounts of copper ions (CuSO4 x 5 H2O) to 10 millimol diethyldithiocarbamate (DETC) 
solved in 10% bovine serum albumin. Copper DETC complex formed in this mixture was used 
as standard. The final iron /copper concentrations ranged from 0 to 25 |jM. Upon reaction with 
RONS, CP-H is transformed into a stable CP^  radical (3-carboxy-proxyl). Standard solutions of 
3-carboxy-proxyl were used to quantify RONS levels in plasma.
RONS and glutathione in skeletal muscle tissue
For reactive oxygen and nitrogen species (RONS) analysis, a small piece of skeletal muscle tissue 
(approximately three hundred fifty |jL) was put in a 1 mL syringe and immediately frozen in 
liquid nitrogen. The sample was then pressed out of the syringe and put in a liquid nitrogen 
Dewar for electron paramagnetic resonance (EPR) analysis as described in the previous para­
graph.
For glutathione analysis, the remaining tissue sample was frozen in liquid nitrogen and 
homogenized in 0.4 M HClO4 using a ball mill. After centrifugation acid extracts were stored at 
-20°C or analyzed immediately by means of ion-pair reversed phase HPLC with electrochemical 
detection. The HPLC-System included a Spherisorb S3ODS-2 column (3 |jm, 125 mm x 4 mm ID; 
Phenomenex, Torrance, CA), a Rheodyne 7125 injector (Rheodyne, Cotati,CA), a PU-980 HPLC 
pump (Jasco, Great Dunmow, United Kingdome), a pulsation dampener (Shodex, Tokyo, Japan), 
and a Coulochem 5100 A electrochemical detector (ESA, Bedford, MA) equipped with a 5011 
analytical cell (+ 0.4 V). Data acquisition and analysis was done with an analog interface AI 406 
and System Gold software (both Beckman Coulter, Fullerton, CA). The mobile phase consisted 
of 0.1 mol/L sodium acetate, 0.1 mol/L sodium hydrogen phosphate, 400 mg/L SDS adjusted to 
pH 2.0, and 2.5% acetonitrile (vol/vol). Calibration curves for reduced glutathione (GSH) were 
established daily. Oxidized glutathione (GSSG) was measured after enzymatic reduction with the 
following assay: 100 |jL acid extract were incubated with 50 |jL 2.5 millimol N-Ethylmaleinimid
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(NEM) and 760 |j L 0.1 M phosphate buffer pH = 7.0 to mask endogenous GSH. Excess of NEM 
was exhausted with 50 |jL 3mM Sodium 2-mercaptoethanesulfonate. GSSG was reduced to 
GSH by addition of 20 |jL 2 mM NADPH and 20 ^L 12 units glutathione reductase and GSH 
was measured by HPLC. Glutathione levels were corrected for skeletal muscle wet weight and 
protein content in order to correct for skeletal muscle oedema.
Study design in vitro experiment
Eight adult male Sprague-Dawley rats (Animal Research Laboratories, Himberg, Vienna, Austria) 
weighing 280 gram ± 21 gram were killed and the hind paw skeletal muscles were quickly 
harvested and stored. Rat skeletal muscle mitochondria were prepared similar as described 
previously with heart mitochondria17. Isolated skeletal muscle mitochondria were incubated 
with Tert-BuOOH and subjected to various reagents in a closed system in vitro to assess changes 
in the rate of oxygen consumption.
Mitochondrial function
Immediately after harvesting mitochondria were stored at 0°C for 4 - 5 hours in a buffer con­
taining 0.25M sucrose, 10 mM Tris _HCl, 0.5 mM EDTA (pH 7.2), and 0.5 g/L essentially fatty 
acid-free bovine serum albumin (BSA). Respiration rates were determined with an Oxygraph-2k 
Respirometer (Oroboros Ltd, Innsbruck, Austria). Skeletal muscle mitochondria were first mixed 
with an incubation buffer containing 80mM potassium chloride, 5mM potassium phosphate, 
20mM Tris-HCl, 1mM DETAPAC and 0.1% BSA (pH 7.4). State 2 rate of respiration was defined as 
the respiration of mitochondria upon addition of a Krebs cycle substrate only. The transition to 
State 2 respiration was achieved by addition of glutamate/malate (5mM + 5mM). After respira­
tion reached a steady state, 0.125 mM ADP was added for transition to State 3 respirations. 
After all ADP was transformed to ATP the State 4 respiration was achieved. The ratio State 3 rate 
/State 4 rate is called the respiration control index (RCI) as it reflects the coupling of oxidation 
and phosphorylation. The mitochondria were preincubated for 2 min with either increasing 
concentrations of Tert-BuOOH (final concentrations 0 - 25 mM) or with double distilled water 
used as a control. The kinetics of oxygen consumption rate was analyzed using a custom-made 
Excel program.
Statistical analysis
All data were analyzed using SPSS (Statistical Package for the Social Sciences version 16.0 for 
Windows; SPSS Inc., Chicago, IL). and are expressed as mean with standard error of the mean. 
RONS, transferrin, ceruloplasmin, and glutathione levels were compared between experimental 
and control rats, and in experimental rats between left (infused) and right (infused contralat­
eral) hind limb using the Mann-Whitney U test. Skin temperature, limb circumference and pain 
responses of the left hind limb were compared with the right hind limb using the Wilcoxon 
signed rank test for paired samples. This test was also used to compare blood gas analysis
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data between the left and right hind limb. For mitochondrial analysis, statistical analysis was 
performed by one-way ANOVA followed by a post hoc test for the least-significant difference. 
Statistical significance was defined as a p-value < 0.05.
resu lts
Most rats developed an abnormal gait and posture (63%), guarding behaviour (63%), and sud­
den licking (75%) of the hind paw 1 - 2 days after the beginning of infusion (Figure 2). Before 
infusion skin temperature difference between the left and right hind paw was 0.06 ± 0.1°C. 
Seven days later, the skin temperature of the infused left hind paw, as compared to the right, 
was on average 1.7 ± 0.4°C (p = 0.043) higher. The average increase of the infused hind paw 
circumference was 2.3 ± 1.5% (p = 0.039). The volume increase of the left foot compared to the 
preoperative situation was 8.2 ± 3.4% after seven days. Colour difference was present in 63% 
of the rats. Spontaneous pain was almost absent after one week. Mechanical stimulation with 
both 5.16 g and 12.5 g von Frey filaments showed negligible withdrawal reaction before infu­
sion. Seven days after infusion, withdrawal was significantly more frequent when stimulating 
with the 5.16 g filament (15 withdrawal responses out of 80 applications)[19 ± 10%; p = 0.068]
Figure 2. After 24 hrs of continuous infusion (1 mL/hr) of Tert-BuOOH (25 mM). The infused left hind 
paw showed increased skin temperature, increased circumference, redness of the plantar skin, impaired 
function and increased pain sensation, while the contralateral right hind paw these signs were absent 
(photo courtesy of L. van der Laan).
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or the 12.5 g filament (30 withdrawal responses out of 80 applications) [38 ± 15%; p = 0.027] 
compared to before Tert-BuOOH infusion. Preoperative observation of the rats on the heated 
plate showed normal behaviour, with a pain score of 0.04 ± 0.1. Seven days after infusion the 
heat pain score of the infused hind paw was significantly increased to 0.76 ± 0.5 (p = 0.028), 
whereas the right limb showed a normal response.
Blood gas analysis
Venous oxygen saturation and venous oxygen tension of the infused left side were significantly 
higher than those of the infused contralateral right side, and lactate levels on the infused side 
tended to be higher (Table 1). These findings were compatible with an impairment of oxygen 
extraction in the infused hind paw.
Levels of RONS, ceruloplasmin and transferrin in plasma
The levels of reactive oxygen and nitrogen species (RONS), ceruloplasmin, and transferrin are 
presented in Table 2. In jugular vein plasma no difference was observed in RONS levels between 
infused rats and controls. Jugular vein plasma levels of the antioxidant ceruloplasmin (CP) were 
significantly higher in infused rats than in controls (7.04 ± 1.01 versus 4.57 ± 0.51, p = 0.037), 
whereas no differences were observed in transferrin (TR) plasma levels (23.59 ± 4.0 versus 25.82 
± 2.09, p = 0.35), on day seven. The antioxidant activity (AOA = CP/TR ratio) tended to be higher 
in infused rats than in controls (0.31 ± 0.1 versus 0.148 ± 0.02, p = 0.063).
Levels of RONS and glutathione in skeletal muscle tissue
In skeletal muscle tissue, no difference was observed in RONS levels between infused left 
side versus control animals in Table 3. RONS levels, however, were elevated compared to the
Table 1. Venous blood gas analysis, left (infused) versus right (contralateral) hind paw.
Parameter infused 
left hind limb
Contralateral 
right hind limb
p-value
pO2 (mm Hg) 38.25 ± 1.46 31.38 ± 1.55 0.012
pH 7.36 ± 0.01 7.36 ± 0.01 1.0
Lactate (mmol/L) 1.35 ± 0.13 1.21 ± 0.08 0.12
SvO2 (%) 53.4 ± 1.98 40.3 ± 2.51 0.012
Table 2. Plasma (jugular vein) concentrations of reactive oxygen nitrogen species (RONS), transferrin,
ceruloplasmin and antioxidant activity (AOA) in Tert-BuOOH infused rats and controls (data are presented 
as mean and standard error of the mean).
Parameter infused animals Control animals p-value
RONS [nmol/cm3 plasma] 4.36 ± 0.83 4.70 ± 0.18 0.51
Transferrin (|jM Fe (III)) 23.59 ± 4.0 25.82 ± 2.09 0.35
Ceruloplasmin (|jM Cu(II)) 7.04 ± 1.01 4.57 ± 0.51 0.037
AOA (Cp/Tr ratio) 0.31 ± 0.1 0.148 ± 0.02 0.063
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Table 3. Muscle tissue concentrations of reactive oxygen nitrogen species (RONS) and glutathione (GSH) in 
Tert-BuOOH infused rats left infused limb versus right not infused contralateral hind limb, and left infused 
hind limb versus left hind limb of controls animals (p-value indicates left versus right hind limb and infused 
versus control animal respectively).
Parameter Experimental animals Control animals p-value
infused Contralateral Left hind limb
left hind limb right hind limb
RONS [nmol/cm3 tissue] 4.48 ± 0.73 2.53 ± 0.14 5.49 ± 0.78 0.11/0.51
GSH [U/mg protein] 7.22 ± 0.75 5.38 ± 0.35 5.72 ± 0.35 0.08/0.14
non-affected right side on day seven after Tert-BuOOH infusion (4.48 ± 0.73 versus 2.53 ± 0.14, 
p = 0.11). Glutathione levels tended to be higher in infused rats than in controls and in the 
contralateral right side (7.22 ± 0.75 versus 5.38 ± 0.35, p = 0.08).
Mitochondrial function
Tert-BuOOH had a pronounced inhibitory effect on mitochondrial function in State 3 with 
increasing doses of Tert-BuOOH (Figure 3). The effect was non-significant in State 2. The respira­
tion control index (RCI), reflecting the coupling of oxidation and phosphorylation in mitochon­
dria, was significantly decreased. This decrease was due to a reduced rate of respiration in State 3.
Tert-BuOOH (mM)
Figure 3. Dose effect of Tert-BuOOH on the respiration rate in State 2 and State 3, and the Respiratory 
Control Index (RCI) in rat skeletal muscle mitochondria. Respiration and RCI are both expressed in 
percentage to control values (in the absence of Tert-BuOOH). State 2 rate of respiration was defined as the 
respiration of mitochondria upon addition of a Krebs cycle substrate only.
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d isc u ss io n
This study demonstrates that local induction of oxygen free radical formation results in a chronic 
state of both local and systemic oxidative stress and impaired oxygen extraction. The same 
inducer of free radicals impairs mitochondrial function by interfering with ATP synthesis indicat­
ing a possible mode of action inducing oxidative stress. The data confirms that continuous intra- 
arterial infusion of a pro-oxidant compound causes long term behaviour in rats that is indicative 
of chronic pain, increased sensitivity for non-painful stimuli and elevated skin temperature. 
These are all elements of CRPS I. Signs of chronic pain and inflammation in the rat hind paw in 
this locally induced oxygen free radical model are similar to those observed in animal models of 
chronic neuropathic pain, such as the chronic constriction injury model (CCI model)22. 
Tert-BuOOH was chosen because it reportedly induces oxidative tissue injury in hepatocytes, 
renal tubules, the brain and skeletal muscle19,20,29-31. Tert-BuOOH is metabolized in the cell by 
glutathione (GSH) peroxidase to glutathione disulfide (GSSG) and tert-butanol. However GSH 
can be overwhelmed by using an excess Tert-BuOOH, leading to the formation of the free radi­
cals tert-butoxyl and tert-butylperoxyl18. The free radical derivatives of Tert-BuOOH can induce 
oxidative injury as a result of lipid peroxidation and mitochondrial dysfunction19,20. In a previ­
ous study infusion of the vehicle of Tert-BuOOH (saline with heparin) no signs or symptoms of 
neuropathic pain were found, histology of skeletal muscle and arteries was unaffected, and 
there was no increase in vascular permeability as measured by 99mTc_IgG15,16. Accordingly, we 
have chosen to use only a non-infusion group as control.
Day seven was chosen for long term measurement of changes in both oxidant and anti­
oxidant activity induced by 24 hours infusion of Tert-BuOOH because signs and symptoms 
of inflammation are still present on this day32 which was confirmed by the present study. 
Seven days after infusion, RONS levels in femoral vein plasma of affected hind paws were 
not higher than those found in controls, challenging our hypothesis. However, measurement 
of free radical concentrations is difficult, because they are extremely short lived and only 
produced in minute quantities. Moreover, jugular vein plasma levels of ceruloplasmin were 
found to be higher in infused rats than in controls indicating an increased level of systemic 
antioxidant activity abolishing free radical formation. It is not known when this compensa­
tory response commences during the seven days period of the experiment. Multiple time 
related observations and measurements would be needed to adequately characterize the 
biological response to Tert-BuOOH infusion.
We have found significantly elevated venous oxygen saturation levels and a tendency of 
higher venous lactate levels in the infused hind limb seven days after Tert-BuOOH infusion. 
High mixed venous oxygen saturations and elevated lactate levels at rest are characteristic 
of a condition with impaired oxygen extraction as it reflects the inability of tissue or muscle 
to utilize oxygen despite sufficient supply11. There are several causes for the high saturations 
levels. First, a deficient autoregulation of the microcirculation, resulting in a widely open
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capillary bed, while only a small fraction of the oxygen supplied is consumed. Second, the 
presence of an increased flow through non-nutritive pathways, such as through arteriovenous 
anastomoses33. Thirdly, a diffusion problem for oxygen between the erythrocytes and the 
mitochondria, probably located in the endothelial cell and capillary basement membrane. 
Finally, reduced oxygen extraction may be present due to mitochondrial dysfunction. With 
respect to the first possibility, no published reports are available for a defective autoregulation 
within healthy skeletal muscle in human or rats. As to the second possibility, arteriovenous 
anastomoses were proven to be present in cat skeletal muscle34, but were not found in human 
temporal skeletal muscle35. We also could not find this type of information on rats. As to the 
possibility of a diffusion problem, we observed in this animal model that most arteries were 
normal, although in previous experiments at day 7 some necrosis of endothelial cells and 
medial layers of the vascular wall was observed32. In this study, histological analysis revealed 
normal arteries, making a diffusion problem unlikely. Mitochondrial dysfunction remain as a 
plausible cause for the high SvO2 levels found. Tert-BuOOH induced oxidative stress is known to 
damage mitochondria by mitochondrial swelling resulting in mitochondrial dysfunction and 
reduction of their respiratory activity36. The observed mitochondrial swelling was attributed 
to an increased inner mitochondrial membrane permeabilization through protein and lipid 
peroxidation. In the present in vitro experiments Tert-BuOOH impaired respiratory function 
mitochondria due to decreased respiration in State 3, reflecting the rate of ATP synthesis and 
did not lower State 2 respiration, reflecting the permeability of the mitochondrial membrane. 
This implies that the mitochondrial energy generating system, reflected by State 3 respira­
tion and the ATP production, is a target for RONS in this model. These data clearly show that 
Tert-BuOOH affects complex I of mitochondria inhibiting the electron transfer. Combining 
data from both experiments support the concept of Tert-BuOOH mediated mitochondrial dys­
function, causing impaired oxygen extraction. This concords with recently published studies 
showing that the contribution of the mitochondria in neuropathic pain was ATP dependent 
and not dependent on inflammatory markers37.
It was hypothesized that signs and symptoms of chronic pain syndromes are caused by 
impaired oxygen extraction secondary to RONS induced mitochondrial dysfunction. An argu­
ment in favour of our hypothesis on the involvement of free radicals in the development of 
signs and symptoms in this rat model of chronic pain is the reduction of pain sensation, skeletal 
muscle and nerve damage and the shortened repair periods after administration of the free 
radical scavenger N-acetyl-l-cysteine, as shown in a previous study32. An argument challeng­
ing our hypothesis regards the possible microvascular dysfunction in skeletal muscle, which is 
associated with allodynia due to muscle ischemia38. Indeed we have observed after one week 
some degree of skeletal muscle necrosis, though the degree of tissue necrosis was variable in 
our rats and not very profound32.
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In conclusion, this study shows that Tert-BuOOH, an inducer of oxidative stress and increased 
RONS generation, causes behaviour indicative of chronic pain in the rat hind limb, increased 
responsiveness to otherwise non-painful mechanical/thermal stimuli as well as increased skin 
temperature. These changes are associated with an impaired oxygen-extraction, which may 
result from mitochondrial dysfunction caused by free radicals as shown in the in vitro experi­
ment.
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Background:
The pathophysiology of Complex Regional Pain Syndrome type I (CRPS I) is still a matter of 
debate. An inflammatory reaction may cause the syndrome. Increasing evidence points to a 
role for impairment of oxygen metabolism in the affected limb.
Methods:
In this pilot study (16 patients) we performed capillary blood gas analysis in extremities with 
acute CRPS I, in order to assess oxygen saturation and lactate levels. Comparison was made with 
the unaffected limb of capillary blood pH, pO2, SaO2, and lactate and glucose concentrations.
Results:
No statistically significant differences could be found.
Conclusion:
Capillary blood gas analysis is not useful to detect changes in oxygen saturation and lactate 
concentrations in CRPS I.
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in tro d u ct io n
Complex Regional Pain Syndrome type I (CRPS I) is a poorly understood syndrome which 
may occur in an extremity after even a minor injury or operation. In the acute phase CRPS I is 
characterized by signs and symptoms of inflammation within the affected extremity. Although 
the clinical signs and symptoms of CRPS I are well known, the underlying pathophysiology 
remains unclear. Sudeck1 hypothesized that an excessive inflammatory reaction may cause the 
syndrome. Recent studies supporting the inflammatory theory include:
1) The dominance of clinical signs and symptoms of inflammation - such as unexplained 
severe pain, oedema, difference in skin temperature, difference in skin colour - in the 
affected extremity at the onset of CRPS I2,
2) An increased extravasation of indium-labeled immunoglobulin as a sign of increased capil­
lary permeability for macromolecules3,
3) An increased deposition of lipofuscin as a sign of oxidative stress3,
4) Increased systemic concentrations of bradykinin and calcitonin gene-related peptide3,
5) A therapeutic response to various oxygen radical scavengers4,
6) Increased lactate concentrations within the skin of the affected extremity in patients with 
CRPS I5,
7) Higher concentrations of interleukin (IL)-6 and tumor necrosis factor-a (TNF-aJ in the 
involved extremity in comparison with the uninvolved extremity6.
In earlier studies, we found significantly elevated oxygen saturation levels in venous blood 
samples, obtained from the vena cubiti in the affected upper extremity, compared with the 
unaffected contralateral limb3,7. Therefore we were interested in assessing capillary oxygen and 
lactate levels in the affected limb.
In this pilot study we performed capillary blood gas measurements in the extremities of the 
affected limb in patients with acute CRPS I in order to asses oxygen saturation and lactate 
concentration compared with the unaffected contralateral limb.
m eth o d s
The study was performed in the out-patient clinic of the Department of Surgery, Radboud 
University Nijmegen Medical Centre. All new patients presenting with signs and symptoms of 
acute CRPS I were invited to participate in the study. Excluded were patients with abnormalities 
in the contralateral limb. The study protocol was approved by the Human Ethical Committee 
Arnhem-Nijmegen.
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The following diagnostic criteria were used in making the diagnosis CRPS I2:
1. Presence of at least 4 of the following 5 signs and symptoms: unexplained diffuse pain and 
tenderness in the distal part of the extremity, difference in skin colour in relation to the 
healthy symmetrical limb, diffuse oedema, difference in skin temperature in relation to the 
healthy symmetrical limb and limited range of movement.
2. An increase in the above signs and symptoms during exercise.
3. The signs and symptoms above were present in an area much larger than the area of pri­
mary injury or operation and including the area distal to the primary injury.
All patients were non-fasting and were managed according to a standardized treatment proto­
col3. After given informed consent, they were brought to a climate-controlled room maintained 
at 24°C and allowed to acclimatize for approximately 15 minutes. Capillary blood was collected 
from a finger or toe of the CRPS I extremity, followed by sampling from the symmetrical part 
of the contralateral unaffected limb. The average time between blood collection and blood 
gas analysis was 7.5 minutes (range 3 - 18 minutes). The blood gas analyses were performed 
with a Chiron 865 blood gas analyser (Bayer BV, Mijdrecht, The Netherlands). Skin temperature 
was measured in triplo with an infrared (ear) thermometer (First Temp "Genius" Digital Ear 
Thermometer; Sherwood Medical, Crawley, United Kindome) held 1 cm above the skin surface. 
The difference between warm and cold is based on the initial skin temperature at the onset of 
the complaints3. The pain was scored according to the visual analogue score (VAS) for pain, in 
which the patient is asked to draw a mark on a 10 cm long line. The left side of the line is marked 
"No pain whatsoever" and the right side "The worst pain imaginable". Subsequently the mark is 
measured in centimetres, resulting in a VAS from 1 and 10.
Statistical analysis was performed using the paired t-test. Results were considered significant 
when p < 0.05.
resu lts
Sixteen patients (4 men, 12 women) were included in this study, with mean (range) age being 
48 (16 - 70) years. Twelve patients (75%) had CRPS I within an upper extremity. In 10 patients 
(62.5%) the right limb was involved. The clinical signs and symptoms started after a minor injury 
in 10 patients, after an operation in five and spontaneously in one. The mean (range) interval 
between the start of symptoms and capillary puncture studies was 7 (0 - 22) months. The mean 
(range) score on the visual analogue painscore was 4.3 (1 - 10) and the mean difference in skin 
temperature was -0.8 (range -5.10 to +1.80)°C.
No statistical significance could be found, comparing the laboratory data between the CRPS I 
limb and the normal limb (Table 1). From five blood samples taken (three in warm CRPS I and
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Table 1. Results of capillary blood gas analyses from patients with Complex Regional Pain Syndrome type I 
(CRPS I), comparing the affected and unaffected limb.
All patients (n = 16) 
CRPs I/ Normal p
Warm CRPs 1 (n = 7) 
CRPs 1/ Normal p
Cold CRPs I (n = 9) 
CRPs I/ Normal p
pO2 9.47 / 9.11 kPa 0.25 10.09 / 9.04 kPa 0.03* 9.05 / 9.14 kPa 0.81
pH 7.42 / 7.41 0.33 7.41 / 7.41 0.82 7.42 / 7.42 0.66
Glucose 6.4 / 6.3 mmol/L 0.45 6.6 / 6.4 mmol/L 0.18 6.3 / 6.3 mmol/L 0.69
Lactate 2.1 / 2.1 mmol/L 0.98 1.9 / 2.3 mmol/L 0.12 2.2 / 1.9 mmol/L 0.55
SO**3au 2 95.8 / 96.2% 0.24 97.4 / 95.9% 0.51 95.5 / 96.2% 0.11
* p < 0.05
** Based on n = 11 patients (4 warm CRPS I and 7 cold CRPS I patients)
two in cold CRPS I patients), no co-oximetry parameters could be calculated and measured 
due to clotting of the sample. As a consequence the co-oximetry parameters are based on 11 
patients. When dividing the patients according to the skin temperature difference, there was a 
significant increase in pO2 in the warm CRPS I limb (10.09 kPa, range 7.24 - 12.11 kPa) versus the 
healthy limb (9.04 kPa, range 6.8 - 10.74 kPa), while lactate concentrations were lower but not 
statistically significant. In the cold group, oxygen saturation tended to be lower.
d isc u ss io n
These results suggest that the differences found in this pilot study merely reflect the differ­
ences in arterial blood flow through the skin in the affected extremity. In a warm extremity 
with CRPS I, arterial blood flow has been shown to be significantly increased, while being 
significantly reduced in cold CRPS I3. Consequently tissue pO2 and O2 saturation values follow 
the same trend, while lactate concentrations depended on the dilution factor caused by the 
arterial blood flow. In addition, in the study of Birklein et al.5, at least six out of nine patients 
were mentioned to have a cold skin temperature, possibly explaining the higher blood lactate 
concentrations found.
co n clusio n
In this study we could not determine significant differences in pO2, oxygen saturation and 
lactate concentration in capillary blood samples from the affected versus the unaffected 
contralateral limb in patients with CRPS I. In capillary blood, pO2 and oxygen saturation were 
close to arterial values. Therefore capillary blood gas analysis may not be sufficiently sensitive 
to detect increases in venous oxygen saturation and lactate production in this condition.
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Background:
The purpose of this study was to evaluate oxygen extraction and utilization in end stage chronic 
Complex Regional Pain Syndrome type I (CRPS I) patients undergoing amputation and to relate 
these to muscle histology of the amputated limb.
Methods:
In 25 patients with severe CRPS I, requiring amputation of the affected limb, venous blood 
samples and in 11 patients skeletal muscle specimens were analyzed.
Results:
The mean venous oxygen saturation (SvO2) value (94.3 ± 4.0%) of the affected limb was signifi­
cantly higher than SvO2 values found in healthy subjects (77.5 ± 9.8%) pointing to a severely 
decreased oxygen diffusion or utilization within the affected limb. Histological analysis showed 
a significant decrease of type I fibers and a significant increase of type IIB fibers. Ultrastructural 
investigations of soleus skeletal muscle capillaries revealed thickened endothelial cells and 
thickened basement membranes. Muscle capillary densities were decreased in comparison 
with literature data. High venous oxygen saturation levels were partially explained by impaired 
diffusion of oxygen due to thickened basement membrane and decreased capillary density.
Conclusion:
Venous oxygen saturation levels are significantly increased in chronic end stage CRPS I patients, 
corresponding with impaired oxygen diffusion. The abnormal skeletal muscle findings points 
to severe disuse but only partially explain the impaired diffusion of oxygen; mitochondrial 
dysfunction seems a likely explanation in addition.
Impaired oxygen utilization in skeletal muscle of CRPS I patients 87
in tro d u ct io n
Complex Regional Pain Syndrome type I (CRPS I) is a poorly understood disease which may 
occur in an extremity after even a minor injury or operation. The reported incidence of CRPS 
I varies between 5.5 - 26.2 per 100.0001,2. Although the clinical presentation of CRPS I is well 
known,3-5 the mechanism of the (chronic) pain and the underlying pathophysiology remains 
subject of debate. An excessive regional inflammatory response, including the production of 
reactive oxygen free radicals, may be involved in both acute and chronic CRPS I patients6. In 
acute CRPS I patients elevated venous oxygen saturation levels have been found7 and cellular 
hypoxia is present as measured by phosphorus nuclear magnetic resonance spectroscopy8. In 
chronic CRPS I patients there are only scarce data on oxygen extraction, utilization and cel­
lular hypoxia pointing at similar pathophysiology compared with acute CRPS I. Histological 
analysis in CRPS I patients by means of a muscle biopsy would be advantageous to evaluate 
cellular changes explaining the before mentioned findings, tough is not advisable because any 
additional injury or invasive procedure may increase the severity or recurrence of CRPS I in an 
affected limb or induce CRPS I in a healthy limb3.
We had the opportunity to measure venous oxygen saturation levels and perform histological 
and electron microscopic analysis of muscle specimens in patients undergoing amputation of 
an extremity, because of therapy-resistant, severe chronic CRPS I. The focus of this study was on 
muscle fibers and capillaries because in a small pilot study by our research group, a decrease 
of type I fibers, atrophic fibers and severely thickened basal membrane layers of the capillaries 
of skeletal muscle was demonstrated,9 pointing at repeated episodes of cell death and cell 
regeneration10.
The objective of this study was twofold; To measure venous oxygen saturation levels in a large 
group of chronic end stage CRPS I patients, and to analyze cellular changes in their skeletal 
muscle possibly explaining venous oxygen saturation.
patients and methods 
Patients
Patients who were advised to undergo amputation of an extremity, because of therapy- 
resistant, severe chronic CRPS I were selected. Before the decision to amputate, all patients had 
been extensively, but unsuccessfully treated with sympathetic blockades, free radical scaven­
gers, occupational therapy and pain-relieving drugs. Amputation of the affected extremity was 
necessary, because CRPS I had resulted in a non-functional limb with severe hyperalgesia. The 
indication for amputation was previously documented in a large study of patients with CRPS 
I11. All patients gave informed consent for blood sampling prior to amputation and patients 
with lower leg amputation for histological and electron microscopic analyses of the amputated
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limb. The study was approved by the university hospital's ethical committee and was in adher­
ence with the principles of the Declaration of Helsinki. Patients were operated according to a 
standard operative technique under general anaesthesia.
Blood samples
After visualizing the main vessels and before clamping, blood gas samples (2 mL) were obtained 
of the superficial femoral (above knee amputation), popliteal (through knee amputation), or 
brachial vein (through or above elbow amputation), and promptly analyzed with the Rapidlab 
865 (Bayer) for pO2, pH, lactate, glucose and venous oxygen saturation (SvO2). In the first ten 
patient in addition to venous blood samples, arterial blood gas analysis was performed.
Skeletal muscle specimens
Fresh skeletal muscle specimens of approximately 20 x 20 x 20 mm were harvested from the 
middle of the tibialis anterior, gastrocnemius and soleus muscles immediately after amputa­
tion. The skeletal muscle specimens were divided into two pieces: one specimen for light 
microscopy (LM) for measurement of fiber type percentage and capillary density (number of 
capillaries/mm2), and one for electron microscopy (EM) for measurement of capillary diameter 
(in micron), and capillary basement membrane thickness (in micron).
For light microscopy a standard batch of staining techniques was carried out on freshly frozen 
transversely cut (10 micron) sections; a hematoxylin and phloxine stain and various enzyme 
histochemical reaction techniques including myofibrillar ATPase, to identify muscle fiber type, 
and succinic dehydrogenase (SDH) and cytochrome oxidase (COX) to detect mitochondrial 
activity and the presence of sharply demarcated regions without mitochondrial activity (also 
known as cores).
Muscle fiber type was determined by using ATPase stained sections (the darkest brown fibers 
represent type I fibers in the ATPase pH 4.2 or 4.6 stain; in the ATPase pH 4.6 stain the unstained 
fibers represent type IIA fibers, the intermediately stained fibers represent type IIB); 100 - 200 
muscle fibers in a representative microscopic field were classified in this way by means of a 
drawing microscope. To estimate muscle fiber atrophy or fiber hypertrophy (four muscle fibers 
per muscle were measured) both the smallest and largest type I and type II fibers were drawn 
using the drawing microscope. Each drawn fiber area was transformed into a circle by hand 
using a template with several circular diameters. The matching diameter served as the measure 
for fiber size.
Endothelial cells were visualized to measure capillary density, with the indirect immunohisto- 
chemical peroxidase method, using monoclonal antibodies against HLA-DR (Class II). Capillary 
density was determined by taking the mean after analyzing 2 small regions (0.136 mm2) in 
a muscle section representing an estimated minimum and maximum density per muscle per
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patient. The analyses were done by counting the number of capillaries from HLA-DR stained 
sections (Figure 1D) by using a drawing microscope.
Electron microscopy (EM) was performed using a transmission electron microscope (JOEL type 
1200EX/II) to measure the capillary basement membrane thickness (CBMT) and other capil­
lary characteristics of soleus muscle. We choose to analyze soleus muscle, because this muscle 
was most affected on light microscopy. For EM fresh skeletal muscle specimens were fixed 
in glutaraldehyde, postfixed in osmium tetroxide, embedded in Epon, cut, and stained with 
uranylacetate and leadcitrate. The first ten observed capillaries per specimen during systematic 
screening were photographed at 6K (6000 times) magnification. CBMT was determined by 
averaging the two interceptions of the short elliptical axis with the basement membrane (BM) 
of the often elliptically cut capillary. Pericyte interceptions were not included in the measure­
ments. Endothelial cell thickness and lumen diameter were calculated in the same way.
Controls
Blood gas control samples were not taken from the contralateral extremity, considering the 
risk of inducing CRPS I in that extremity. Patients matched for age and sex, undergoing elective 
surgery with general anaesthesia (removal of osteosynthesis material, laparoscopic cholecys­
tectomy, excision of breastlump and treatment of anal fistula) were used as controls for blood 
gas analysis. Immediately after induction of anaesthesia and before incision, blood samples (2 
mL) were taken from the femoral vein and promptly analyzed with the Rapidlab 865 (Bayer) for 
pO2, pH, lactate, glucose and venous oxygen saturation (SvO2).
For fiber type I and II and capillary density data available in literature were used as reference. 
Sample size, mean and standard error of the mean were recorded from these studies12-21.
No control specimens of soleus muscle were available to obtain control data on capillary base­
ment membrane thickness. Therefore we used data of quadriceps muscle biopsies from an age 
matched healthy control group, included in a study on hyperthermia22. A correction factor of 1.5 
was applied because the mean BM of lower leg (soleus) muscle is on average 1.5 times thicker 
than that of quadriceps capillaries attributed to increased venous hydrostatic pressure23.
Statistical analysis
Mean venous oxygen saturation levels (SvO2) of the CRPS I patients were compared with the 
mean SvO2 of control patients by their 95% confidence intervals (CI). The unpaired sampled 
t-test was used to compare the morphological data (mean and standard error of the mean) 
compared with literature values. Regression analysis (curve estimation, quadratic model) was 
used to correlate age, CRPS I duration and morphological data (muscle fiber type parameters 
(type I and type IIB), capillary densities of all three different muscle specimens, and EM capillary 
parameters) with SvO2. A p-value < 0.05 was considered significant.
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Patients
Twenty-five patients who underwent an amputation were included in this study (Table 1). All 
patients fulfilled the diagnostic criteria of the International Association for the Study of Pain 
(IASP)4 and Veldman et al.3; discoloration of the skin, severe limitation of the active range of 
motion, extreme paresis, severe spontaneous pain, hyperalgesia and allodynia, and atrophy of 
skin, subcutaneous tissue and skeletal muscles were present in the affected extremity. Twenty- 
one were lower extremity amputations (7 through knee, 14 above knee), and 4 upper extremity 
amputations (three above elbow and one through elbow). The mean age at operation was 38 
years (range: 17 to 61 years). The mean duration of CRPS I symptoms was 7.1 years (range 6 
months to 24 years). In 81% of the cases CRPS I was induced by a minor injury, an operation, a 
contusion or sprain. Seven patients were smokers and 8 patients still used vasodilator drugs as 
treatment for CRPS I. None of the patients had migraine, were diabetic, had gastro-intestinal 
dysmotility problems, anxiety or were known with central or peripheral nervous system disease 
or peripheral vascular disease.
Blood samples
Arterial values (n = 10) were normal (data not shown). Venous oxygen saturation levels (n = 
25) were significantly higher compared to the healthy matched control population (n = 16) 
undergoing elective surgery under general anaesthesia (removal of osteosynthesis material in 
6, laparoscopic cholecystectomy in 2, excision of breastlump in 4, and treatment of anal fistula 
in 4). The pooled mean of the 25 CRPS I patients SvO2 was 94.3% (95%-CI: 92.6 - 95.9%). In the 
healthy matched control population (n = 16) the pooled mean was 77.5% (95%-CI: 72.3 - 82.7%) 
(p < 0.001) (Table 2). No differences were found in glucose or lactate levels between CRPS I 
patients and the healthy matched control population.
Skeletal muscle specimens
On light microscopic examination the skeletal muscle specimens of lower leg amputations (n 
= 11) showed no signs of cellular inflammation, necrosis or oedema. In Table 3 the most fre­
quently found morphologic abnormalities are summarized, including a significantly decreased 
percentage of type I fibers and a significantly increased percentage of type IIB fibers. In CRPS I 
patients, atrophic type I and type II fibers were frequently found, often with an angular appear­
ance, and in most specimens (Figure 1C) some centrally located unstained regions (cores) were 
present (especially in type I fibers) as identified by SDH, COX, and ATPase stains. Type IIB fiber 
percentages were twice normal in tibialis anterior and gastrocnemius muscle and were even 
increased with a factor 3 in the soleus muscle. Capillary density was decreased in soleus and 
tibialis anterior muscle as compared to literature data (Table 4).
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Table 1. Twenty-five patients with therapy-resistant severe chronic CRPS I.
Nr sex Age
(?)
Etiology Duration 
CRPs 1 (y)
Indication Amputation
level
1 Female# 35 Sprain 4 Persistent infection, severe 
oedema, no function
Through knee
2 Female# 61 Spontaneous 21 Persistent infection, no function Above knee
3 Male# 35 Sprain 4 No function,
severe oedema
Above knee
4 Female 58 Spontaneous 1 No function Through elbow
5 Female# 34 Minor injury 3 No function, extreme 
equinovarus
Above knee
6 Female# 37 Minor injury 16 Persistent infection, severe
oedema,
no function
Above knee
7 Female# 53 Minor injury 5 No function Above knee
8 Female# 21 Minor injury 5 Oedema,
chronic ulceration, no function
Above knee
9 Female# 36 Postoperative 5 No function, persistent infection Above knee
10 Female# 28 Injury 8 No function, 
chronic ulceration
Above knee
11 Female# 33 Sprain 7 Severe oedema, chronic 
ulceration, no function
Through knee
12 Female# 24 Minor injury 10 No function, 
chronic ulceration
Through knee
13 Female 47 Contusion 4 No function Above knee
14 Female 40 Spontaneous 5 Severe oedema chronic 
ulceration
Above knee
15 Female 39 Postoperative 10 No function, 
hygienic problem
Above elbow
16 Female 26 Sprain 3 No function, 
extreme equinovarus
Through knee
17 Female 41 Spontaneous 2 No function, dystonia Through knee
18 Female 45 Minor injury 12 No function Through knee
19 Female 22 Sprain 9 No function Above knee 
amputation
20 Female 58 Phlebotrombosis 1 Oedema, chronic infection Above knee
21 Female 32 Minor injury 10 No function, 
hygienic problem
Above knee
22 Male 31 Minor injury 1 Severe oedema, skin problems, 
clenched fist syndrome, 
no function
Above elbow
23 Male 55 Postoperative 4 No function Above elbow
24 Female 17 Injury 5 No function, 
chronic ulceration
Above knee
25 Female 41 Injury 24 No function Through knee
# Patients with histology samples
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Table 2. Blood samples from CRPS I patients and control patient (data are presented as mean and standard 
error of the mean).
Venous (n = 25) Control (n = 16)
pO2 11.0 ± 3.7 kPa 6.1 ± 1.2 kPa**
pH 7.36 ± 0.06 7.38 ± 0.01
Lactate 1.7 ± 1.0 mmol/L 1.7 ± 0.7 mmol/L
Glucose 6.6 ± 1.7 mmol/L 5.3 ± 0.2 mmol/L
SvO2 94.3 ± 4.0% 77.5 ± 2.5%**
**p < 0.01
Table 3. Characteristics of skeletal muscle fiber type of CRPS I patients and literature (data are presented as 
mean and standard error of the mean).
Skeletal muscle type CRPS i patients Literature 
normal healthy 
patients
Reference nr
Soleus
Type i fibers 
(percentage)
26.4 ± 6.4 (n = 11) 86.4 ± 4.6** (n = 6) 12
Tibialis anterior 55.4 ± 5.5 (n = 11) 73.4 ± 4.2** (n = 6) 12
Gastrocnemius 22.5 ± 3.6 (n = 11) 50.8 ± 1.9** (n = 6) 12
Soleus
Type MB fibers 
(percentage)
51.3 ± 7.2 (n = 10) 13.0 ± 1.6** (n = 8) 13
Tibialis anterior 19.8 ± 5.1 (n = 11) 8.8 ± 2.4* (n = 8) 13
Gastrocnemius 57.2 ± 5.5 (n = 11) 24.2 ± 2.3** (n = 8) 13
* p < 0.05 
**p < 0.01
Electron microscopy showed a significantly thickened (multiplicated) basement membrane 
(BM) (Figure 1A), swollen endothelial cells (increased endothelial cell thickness) and a smaller 
capillary lumen (Table 5). In some patients necrotic capillaries (without endothelial cells but 
identifiable by their BM (Figure 1B)) were seen. The mean capillary BM thickness of the soleus 
muscle was 0.67 micron (SD 0.17), compared to 0.34 micron (SD 0.07) in the quadriceps muscle 
of the control group (Table 5). Comparing the corrected control values (factor 1.5)23 with soleus 
muscle specimens from CRPS I patients, the difference was statistically significant.
Using regression analysis correlation coefficients were calculated for SvO2 versus age, CRPS I 
duration, the muscle fiber type parameters (type I and type IIB), capillary densities of soleus, 
gastrocnemius, and tibialis anterior muscle, and EM capillary parameters. There was a weak 
significant correlation between the SvO2 and BM thickness (R = 0.64, p = 0 .048). Other correla­
tion coefficients were not significant (Figure 2).
Impaired oxygen utilization in skeletal muscle of CRPS I patients 93
Figure 1. Light (C and D) and electron microscopy (A and B) of soleus muscle from patient 7 (A) and 10 (B, C, 
and D) (black bars represent 1 micron in A and B, 50 micron in C, and 100 micron in D).
DISCUSSION
The main outcome of this study was threefold; venous oxygen saturation was elevated in 
this large group of chronic end stage CRPS I patients, histological findings pointed to disuse 
atrophy in chronic CRPS I patients, and basement membrane thickness correlated with oxygen 
saturation levels. Based on the 95% -CI, the mean SvO2 of CRPS I patients was 94.3%, while 
the calculated mean from controls was 77.5%. Control values are not biased, because healthy 
subjects of 18 - 50 years,24 healthy subjects exercising25 and patients undergoing femoro- 
popliteal bypass grafting26 showed a calculated venous oxygen saturation of 83%, which is also 
significantly lower in comparison with the 94.3% in CRPS I patients. High mixed venous oxygen 
saturations and high lactate levels at rest are characteristics of sepsis, of acute respiratory 
distress syndrome, systemic inflammatory response syndrome, and multiple organ dysfunc­
tion syndrome27. This condition has been called "impaired oxygen extraction" as it points to 
the inability of tissue or muscle to utilize oxygen despite an adequate oxygen supply7,28. In
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Table 4. Capillary density (number/mm2) in CRPS I patients and literature (data are presented as mean and 
standard deviation).
Skeletal muscle CRPS i patients Literature 
normal healthy patients
Reference nr
Soleus 299.8 ± 91.1 (n = 11) 288 ± 58 (n = 4) 14
417 (range 333 - 592) (n = 12)** 15
503.2 ± 76.3 (n = 6)** 16
Tibialis anterior 302.5 ± 66.4 (n = 11) 387± 53 (n = 28)** 17
394 ± 44 (n = 30)** 18
403 ± 49 (n = 6)** 19
Gastrocnemius 301.8 ± 81.5 (n = 11) 365 ± 56 (n = 4)* 14
257 ± 44 (n = 23) 20
271 ± 80 (n = 20) 21
* p < 0.05 
**p < 0.01
Table 5. Characteristics of capillaries of soleus muscle of CRPS I patients compared with healthy control 
quadriceps muscle (data are presented as mean and standard deviation).
Capillaries: CRPS i patients (n = 11) 
Soleus (micron)
Controls (n = 10) 
Quadriceps (micron)
Total diameter 5.46 ± 0.47 4.94 ± 0.62*
Diameter without BM 4.11 ± 0.32 4.27 ± 0.56
BM thickness 0.67 ± 0.17 0.34 ± 0.07**
Endothelial cell thickness 0.93 ± 0.41 0.59 ± 0.23*
Lumen diameter 2.25 ± 0.91 3.10 ± 0.59*
* p < 0.05 
**p < 0.01
our patient group, arterial oxygen delivery seems sufficient, given a normal cardiac output (as 
reflected by a normal heart rate and the absence of cardiovascular disease) and normal arte­
rial oxygen saturation values. Besides high venous oxygen saturation levels, increased lactate 
production points to impairment of oxygen metabolism. Birklein et al. found in CRPS I patients 
elevated skin lactate levels using microdialysis, though normal venous blood lactate taken 
from the antecubital veins29. This is consistent with our findings of normal lactate and may be 
attributed to adaptation of the cells to cellular hypoxia. Venous lactate also hardly reflects tissue 
lactate, as the skin contributes only 5% to the whole body lactate turnover. Moreover, blood 
circulation or blood glucose utilization influence the venous lactate level29.
The previous pilot study of skeletal muscle tissue biopsies in chronic CRPS I patients showed a 
decrease in type I fibers, many atrophic fibers and severely thickened basal membrane layers of 
the capillaries9, the latter finding being similar to histologic abnormalities observed in muscles 
of diabetes patients10. In this study we confirmed these findings but in addition detected fibers 
(especially type I) with centrally located unstained regions (cores) with SDH, COX, and ATPase 
stains. The outspoken atrophy and the central core lesions are more in accordance with disuse 
atrophy30-33. In a study of 14 patients with amputated extremities following therapy resistant
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Figure 2. Scatter diagram of: BM thickness and SvO2 values. SvO2 and BM thickness show a significantly 
positive linear correlation. Correlation-coefficient R is 0.64 and R2 is 0.41. BM = Basement membrane; 
SvO2= Venous saturation of oxygen; nm = nanometer (1000 nm = 1 micron).
longstanding CRPS I, both type I and type II fiber atrophy was found34. In 5 out of 14 patients 
signs of morphological denervation or reinnervation (as seen by type grouping) were observed 
and the authors rather concluded to a neuropathic or vascular cause than to disuse as the most 
important factor34. These clear signs of type grouping were observed in some intrinsic foot 
muscles. Generally, type grouping of type I or type II fibers points to muscle fiber reinnerva­
tion35. However, type grouping can also occur normally in some muscles36. In contrast to our 
study, we did not find type grouping in the samples of the investigated large muscle.
Low capillary density and thickened capillary wall might explain impaired oxygen extraction 
due to impaired diffusion. To detect and measure capillary density HLA-DR immune staining 
was preferred above the usual amylase-PAS method, because it gives better contrast against 
background and is therefore more accurate for detecting capillaries37-39. Capillary density was 
moderately decreased in soleus and tibialis anterior muscle, probably caused by disuse-adapted 
regression of the capillary network40, while capillaries revealed normal total diameters. The BM 
thickness in skeletal muscle in our patients was increased by about 50% and venous oxygen 
saturation levels correlated with BM thickness; the thickest BMs were measured in patients with 
the highest SvO2, reflecting low oxygen extraction levels. At rest, however, a 50% increase in BM 
thickness will not lead to hypoxia since in sedentary people oxygen demand is low41. It seems 
therefore that the found BM thickness (50% increase, maximal contribution a factor 2 thicker) 
is related to oxygen consumption levels, implying that other mechanisms than BM thickness 
may be involved.
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Type I fibers normally contain the highest and type IIB fibers the lowest number of mitochon­
dria. We have found a significant decrease in type I fibers, pointing to a considerable loss 
of mitochondria in the lower leg muscles in our CRPS I patients. Notably, lower leg muscles 
predominantly contain type I fiber. By using the ultrastructural data regarding mitochondrial 
content in various fiber types42, it was calculated that the structural mitochondrial loss in CRPS I 
patients amounts to respectively 49, 16, and 45% for soleus, tibialis anterior and gastrocnemius 
muscle, assuming a twofold decreased diameter of type IIB fibers. The above percentages of 
loss in the number of mitochondria found in soleus and gastrocnemius muscles are significantly 
higher compared to the 17% relative loss found in volunteers after a 42-day period of bed rest 
in the vastus lateralis muscle43. Most likely this significant loss of mitochondria is due to the fact 
that CRPS I patients do not exercise, because moving muscles of the affected extremity induce 
or increase pain. Another explanation is the increased fatigability, which is present in more than 
half of CRPS I patients from the very beginning3. Our histological findings of muscles of CRPS 
I patients best correspond with disuse atrophy coupled with decreased mitochondrial activity 
and increased fatigability44.
There is clinical and experimental evidence that an excessive regional inflammatory response, 
including the production of reactive oxygen free radicals, is involved in CRPS I and causes tissue 
damage3,8,45,46. Serum lipid peroxidation products and salivary antioxidative parameters are 
increased in CRPS I patients6. Increased production of oxygen radicals can be a consequence 
of mitochondrial respiratory chain dysfunction. Defective mitochondrial function might also 
explain the nuclear magnetic resonance spectroscopy findings in CRPS I patients, with increased 
anorganic phosphate to creatine phosphate ratios at rest, pointing to cellular hypoxia8. The 
in sedentary people observed morphological abnormalities cannot entirely explain the high 
venous oxygen saturation values. A likely contributing factor is the presence of defective 
mitochondria explaining the impaired oxygen extraction found because muscle mitochondria 
are the decisive structures for oxygen metabolism. The decrease in type I fibers and thus the 
loss of mitochondria support the hypothesis of mitochondrial involvement. We are currently 
investigating the role of mitochondrial dysfunction in CRPS I, in order to further elucidate the 
pathophysiology of CRPS I.
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ABSTRACT
Background:
Reactive oxygen species (ROS) are known to be involved in the pathophysiology of Complex 
Regional Pain Syndrome type I (CRPS I). Since the mitochondrial respiratory chain is a major 
source of ROS, we hypothesized that mitochondria play a role in the pathophysiology of CRPS I.
Methods:
The hypothesis was tested by studying mitochondrial energy metabolism in muscle tissue from 
amputated limbs of CRPS I patients.
Results:
We observed that mitochondria obtained from CRPS I muscle tissue displayed reduced mito­
chondrial ATP production and substrate oxidation rates in comparison to control muscle tissue 
and in comparison with muscle tissue from patients with arterial occlusive disease (AOD). More­
over, we observed reactive oxygen species ROS evoked damage to mitochondrial proteins and 
reduced MnSOD levels in CRPS I patients. No ROS evoked damage to mitochondrial proteins 
was observed in AOD patients while MnSOD levels were increased in these patients.
Conclusion:
The observation of a reduced mitochondrial energy production combined with reactive oxy­
gen species induced damage in muscle tissue from CRPS I patients provides evidence for the 
involvement of mitochondrial dysfunctioning in the pathophysiology of CRPS I.
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INTRODUCTION
Complex Regional Pain Syndrome type I (CRPS I) is a severe, disabling, and painful disease 
which may occur in an extremity after a trauma or injury. In the Dutch population the esti­
mated incidence is 4000 per year, which includes approximately three times more females than 
males1. Clinical features include spontaneous and stimulus-evoked pain, oedema, vasomotor 
and sudomotor disturbances, motor dysfunction, and trophic changes, without evidence for 
peripheral nerve injury according to IASP criteria2,3. Despite growing knowledge of the patho­
physiology of CRPS I, the primary cause of the syndrome is still unknown. In a recent study of 
41 randomized controlled trials about treatment of CRPS I only limited evidence to formulate 
recommendations for treatment of CRPS I was found4. Possibilities for therapeutic intervention 
are therefore limited and include pharmacological pain relief, administration of radical scav­
engers5,6, anti-inflammatory treatment, treatment with biphosphonates7 and physical therapy. 
There are indications for an impaired oxygen metabolism in skeletal muscle of CRPS I patients8. 
In physiological processes like development, and pathological circumstances like tumori- 
genesis, cells are exposed to hypoxia or reduced oxygen levels. Under these circumstances 
elevated levels of reactive oxygen species (ROS) are produced, acting as second messengers 
by activating hypoxia-inducible factors (HIFs) that stimulate the cells to maintain normal ATP 
synthesis9. Under hypoxic conditions, muscle tissue fails to maintain a normal redox state, 
resulting in an increased production of ROS, and subsequent cell injury or dysfunction10. 
Serum lipid peroxidation products and salivary antioxidative parameters, known to be induced 
by ROS, are increased in CRPS I patients11. Increased ROS production can be a consequence 
of mitochondrial respiratory chain dysfunction, part of the mitochondrial energy generating 
system (MEGS). We hypothesized that mitochondrial dysfunctioning due to lack of oxygen 
and subsequent elevated ROS production is involved in the pathogenesis of CRPS I. To test 
this hypothesis, we examined the mitochondrial energy generating system in affected muscle 
tissue of CRPS I patients and in arterial occlusive disease (AOD) patients with hypoxia in an 
affected limb but without CRPS I characteristics.
METHODS 
Patients
Eight patients (seven females, one male) with severe, chronic CRPS I of an extremity, fulfill­
ing the diagnostic criteria of the IASP3 and Veldman et al.12 were included in this study. All 
patients had been extensively, though unsuccessfully, treated with sympathetic blockades, free 
radical scavengers, occupational therapy and pain-relieving drugs. Amputation of the affected 
extremity was advised because CRPS I had resulted in a non-functional limb with severe hyper­
algesia, impairing other functions. The indication for amputation was previously documented
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in a large study of patients with CRPS I13. Six male patients suffering from AOD were included 
in this study. The study was approved by the University Hospital Ethical Committee and was 
performed in adherence with the principles of the Declaration of Helsinki. Informed consent 
was obtained to acquire blood samples and muscle tissue of the amputated extremities to 
perform the biochemical studies. All measured parameters were compared with the control 
muscle samples published before14. In these control muscle samples we found no statistically 
significant differences between males and females. Blood gas samples were obtained at the 
beginning of the operation, after visualizing the superficial femoral vein and artery, and before 
clamping, and promptly analyzed with the Rapidlab 865 (Bayer).
Biochemical and molecular genetic studies
The MEGS encompasses the whole chain of mitochondrial enzymatic reactions involved 
in the generation of ATP, including: (I) transport of pyruvate and other substrates into the 
mitochondrion, (II) oxidation of pyruvate by the pyruvate dehydrogenase complex to acetyl- 
CoA, NADH and CO2 , (III) oxidation of acetyl-CoA to CO2 in the tricarboxylic acid cycle to yield 
NADH and FADH2, (IV) oxidation of NADH and FADH2 in the respiratory chain with subsequent 
coupled ATP production by complex V, and (V) transport of ATP out of the mitochondrion by 
the adenine nucleotide translocator. Immediately after amputation of the affected limb, fresh 
muscle specimens (M. gastrocnemius of seven CRPS I patients, and six AOD patients, and the M. 
extensor digitorum of one CRPS I patient) were obtained and put in ice-cold sample buffer as 
described before14. Within one hour, mitochondrial enriched fractions were prepared and the 
MEGS capacity was measured as described14. In two CRPS I patients, a fresh sample could not 
be obtained and instead the muscle sample was snap frozen in liquid nitrogen immediately 
after collection. Mitochondria-enriched fractions were prepared essentially following the same 
procedure as for fresh muscle samples. As frozen samples are not suitable for analysis of sub­
strate oxidations or ATP production, only respiratory chain enzyme activities were measured in 
these samples. In both fresh and frozen samples, respiratory chain complexes II, III, IV and citrate 
synthase were measured as described before11,15-18. Respiratory chain complex I in the control 
samples and the CRPS I samples was measured as described by Fischer et al.11, complex I in 
the AOD samples was measured as described by Janssen et al.15. To compare the three groups 
mutually, a relative complex I activity was calculated by expressing complex I activity for each 
patient of a distinct group as a percentage of the mean control value for the group in ques­
tion. Citrate synthase activity was measured as a mitochondrial marker enzyme. Protein was 
measured by the method of Lowry et al.19. The complete mitochondrial genome was studied 
in muscle tissue of the CRPS I patients with the Affymetrix Gene Chip' Human Mitochondrial 
Resequencing Array 2.0, according to the manufacturer's instructions with minor modifications 
(www.affymetrix.com).
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Immunochemical studies on muscle mitochondria
Mitochondrial fractions were isolated as described11. Isolated mitochondrial fractions were 
subjected to immunoblotting for carbonylated proteins, manganese superoxide dismutase 
(MnSOD) and porine. Protein carbonylation, as a measure of oxidative damage, was studied 
using the Oxyblot™ Oxidized Protein Detection Kit (Chemicon) in isolated muscle mitochon­
drial fractions according to the manufacturer's instructions with minor modifications (www. 
millipore.com/catalogue/item/s7150#). IRDyeTM 680 conjugated goat-anti-rabbit IgG (Licor) 
was used as second antibody. MnSOD was studied with rabbit-anti-MnSOD (Stressgen) as first 
antibody and IRDyeTM 800 conjugated goat-anti-rabbit IgG (Licor) as second antibody. Porin 
was used to normalize for the amount of mitochondrial protein in each lane. For detection of 
this protein Mouse Anti-porin 31-HL (Ab-3) (Calbiochem) was used as primary antibody. IRDy- 
eTM 800 or IRDyeTM 680 conjugated goat-anti-mouse IgG (Licor) were used as second antibodies 
for the Oxyblot and the MnSOD blot, respectively. The blots were scanned on a Licor Odyssey 
scanner. Missing data due to limited availability of muscle sample are MnSOD in patients 4 and 
5 and oxyblot in patients 4 and 6 of the CRPS I group.
Statistics
Biochemical data of the MEGS and the respiratory chain enzymes of the CRPS I patients, the 
AOD patients and 42 control individuals14 were compared using the non-parametric Wilcoxon 
test. Differences were considered to be statistically significant if p < 0.01.
Table 1. SvO2 observed in controls, CRPS I and AOD patients included in this study.
Gender Age
(years)
Duration of CRPS i 
(years)
SvO2
(%)
CRPS i patient
1 Female 38 4 85
2 Female 34 3 91
3 Female 60 21 92
4 Female 57 1 93
5 Male 34 4 97
6 Female 41 24 99
7 Female 24 10 94
8 Female 20 5 95
AOD patient
1 Male 62 59
2 Male 78 nd
3 Male 80 70
4 Male 46 52
5 Male 71 88
6 Male 76 91
Control patients 
n = 16 Controls mean (range)
77.5 
(72.3 - 82.7)
nd = not determined
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Table 2. Biochemical analysis of the mitochondrial energy generating system (MEGS) in muscle tissue of 
controls, CRPS I and AOD patients.
Muscle investigated pyr+mala mal+pyra suc+acca ATP3
CRPS i patient
1 M. gastrocnemius 5.13 6.61 4.08 52.7
2 M. gastrocnemius 0.87 1.20 nd 10.6
3 M. gastrocnemius 5.17 5.58 3.46 44.7
4 M. extensor digitorum 3.91 4.77 2.88 46.6
5 M. gastrocnemius 1.64 1.46 1.37 1.9
6 M. gastrocnemius 2.51 2.95 1.89 23.6
7 M. gastrocnemius ndb ndb ndb ndb
8 M. gastrocnemius ndb ndb ndb ndb
AOD patient
1 M. gastrocnemius 7.81 6.57 4.78 53.2
2 M. gastrocnemius 4.62 4.07 3.61 48.5
3 M. gastrocnemius 3.67 3.90 3.56 37.3
4 M. gastrocnemius 6.46 6.82 4.26 62.8
5 M. gastrocnemius 7.78 6.19 3.54 39.5
6 M. gastrocnemius 4.99 4.53 2.25 41.8
Control patient Controls (observed range) 3.45-7.99 3.28-8.80 2.03-4.18 36.0-81.7
Controls range (mean±2sd) 3.51-8.01 3.78-8.96 2.04-4.26 36.1-76.8
n 42 41 33 40
p Wilcoxon test: 
Controls versus CRPS I 0.002 0.005 0.517 0.002
p Wilcoxon test: 
Controls versus AOD 0.963 0.104 0.08 0.047
p Wilcoxon test: 
AOD versus CRPS I 0.078 0.262 0.1 0.2
a Substrate oxidation rates and ATP production rates are given in nmol 14CO2 or ATP/hour. mU citrate 
synthase (CS), respectively.
b As in CRPS I patients 7 and 8 a frozen muscle sample was examinated, ATP production and substrate 
oxidation rates could not be measured. 
nd = not determined
RESULTS
Table 1 gives the venous oxygen saturation values measured in venous blood of the affected 
limb of CRPS I patients 93.3 ± 1.5%, AOD patients 72.0 ± 7.7% and 16 healthy control sub­
jects (77.5 ± 2.5%, Chapter 8) just prior to the amputation, showing that the SvO2 values were 
increased in the CRPS I patients and in two AOD patients compared to healthy control patients 
undergoing elective surgery. We examined the mitochondrial energy metabolism in muscle 
prepared from the amputated limbs. The MEGS parameters (oxidation rates of [1-14C]pyruvate 
+ malate + ADP, [U-14C]malate + pyruvate + ADP, and the ATP production rate from oxidation 
of pyruvate) were significantly lower in the CRPS I group compared to the control group, and
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Table 3. Biochemical analysis of the respiratory chain enzymes in muscle tissue of controls, CRPS I and AOD 
patients.
Muscle investigated Complex Complex Complex Complex CSc
id iib iiib ivb
CRPs  i patient
1 M. gastrocnemius 107 566 3322 1674 171
2 M. gastrocnemius 85 545 2242 1597 26
3 M. gastrocnemius 64 457 3047 1078 105
4 M. extensor digitorum 97 627 2738 1471 43
5 M. gastrocnemius 57 357 1942 1339 46
6 M. gastrocnemius 73 441 2050 1449 28
AoD patient
1 M. gastrocnemius 83 577 3331 1517 38
2 M. gastrocnemius 88 844 3610 1252 17
3 M. gastrocnemius 98 741 3154 949 86
4 M. gastrocnemius 63 737 3376 1081 70
5 M. gastrocnemius 77 680 2867 1839 72
6 M. gastrocnemius 67 840 3518 1341 55
Controls
Control patient (observed range)a 
Controls range
62-192 333-853 2057-4964 1201-2938 23-178
(mean±2sd)a 53-147 359-884 1899-4569 1099-2563 22-168
n 41 35 35 42 42
p Wilcoxon test:
Controls versus CRPS I 0.045 0.024 0.034 0.076 0.115
p Wilcoxon test:
Controls versus AOD 0.031 0.036 0.555 0.021 0.016
p Wilcoxon test:
AOD versus CRPS I 1.0 0.006 0.016 0.522 1.0
CRPs  i patient Muscle investigated Complex Complex Complex Complex CSc
ib iib iiib ivb
7 M. gastrocnemius 65 nd 1192 878 nd
8 M. gastrocnemius 
Controls
108 nd 1289 1088 nd
(observed range)a 101-389 nd 1020-2530 520-2080 nd
a Samples from CRPS I patients 1 - 6 and the AOD patients were "fresh” muscle biopsies, whereas for CRPS I 
patients 7 and 8 the biopsies were frozen after collection. Therefore samples were processed in a different 
manner and different control values apply.
b Complex II, III and IV activity in fresh muscle tissue are given in mU/U CS. Complex I and III activity in frozen 
muscle.
c CS activity is given in mU/mg protein
d Complex I activity is given as a relative activity as described in the methods section. 
nd = not determined
did not significantly differ between the AOD patients and controls (Table 2). Although all 
values of the MEGS parameters measured in the AOD patients were within the control range, 
we found no statistically significant difference between the CRPS I and the AOD group. All 
MEGS parameters were significantly decreased in three out of six CRPS I patients. The oxidation
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Figure 1. ATP production rates, complex I and complex II activities in muscle of controls, CRPS I patients 
and AOD patients.
Dot plots for the ATP production  rates, com plex I activ ity  and  com plex II activity. ATP p roduction is expressed in nm oles ATP/hour.mU 
citrate synthase, com plex I as a relative activ ity  (see m ethods section), and com plex II as mU/U citrate synthase.
I  Controls, A  CRPS I patients, ▼  AOD patients.
**: p < 0.01 in the W ilcoxon test.
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figure 2. Immunoblots for oxidatively damaged mitochondrial proteins (Oxyblot) and MnSOD in muscle 
mitochondria from CRPS I patients.
-  97 kDa
Oxyblot
Porin ■ — 21 kDa
Patient 2 5 1 3 7 8 C C
MnSOD 
Porin 
Patient 2 1 3 7 8 6 C C
Patients 2 and 7 show an increased amount of oxidatively damaged proteins (top panel) and reduced 
MnSOD levels (bottom panel). The immunoblot for porin from the same gel is presented below each single 
blot. Molecular weights indicated on the right are based on a molecular weight marker run on the same 
gels. Patient numbering is the same as in Table 1.
rate of [1,4-14C]succinate + acetylcarnitine was significantly decreased in two of five patients. 
We found no significant differences for the respiratory chain enzymes complex I, III and IV 
between the three groups (Table 3). Complex II activity was significantly increased in the AOD 
group compared to the CRPS I group (Table 3). All respiratory chain enzyme activities were 
normal in the CRPS I and the AOD patients, except complex IV activity that was slightly, but 
significantly, decreased in one CRPS I and two AOD patients. In one of two CRPS I patients we 
found a decreased activity of complex I in frozen muscle tissue. Typical dot plots for the MEGS 
parameters (ATP production rate) and respiratory chain enzymes (complex I and II activity) are 
presented in Figure 1. In search for evidence of elevated ROS, we tested for the presence of 
oxidatively damaged proteins in CRPS I and AOD muscle. In all the CRPS I patients we found 
a varying degree of increase of oxidatively damaged mitochondrial proteins (Figure 2). In 
patients 2 and 7 a strong increase in oxidatively damaged proteins was observed. In patients
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figure 3. Immunoblots for oxidatively damaged mitochondrial proteins (Oxyblot) and MnSOD in muscle 
mitochondria from AOD patients.
250 kDa 
150 kDa 
100 kDa
Oxyblot
Porin 
Patient
MnSOD
Porin
Patient
37 kDa
1 2 3 4 5 6 C1 C2
1 2 3 4 5 6 C1 C2
Patient 2 shows an increased amount of oxidatively damaged proteins in relation to the amount of the 
mitochondrial marker protein porin (top panel) and increased amounts of MnSOD in patients 1, 3, 4, 5 
and 6 (bottom panel). The immunoblot for porin from the same gel is presented below each single blot. 
Molecular weights indicated on the left are based on a molecular weight marker run on the same gels. 
Patient numbering is the same as in Table 1.
1, 3, 5, and 8, there was an clear increased amount of oxidatively damaged proteins with a 
molecular weight of approximately 250 KDa, while in proteins of lower molecular weight the 
level of oxidative protein damage appeared to be similar to controls. Although the nature of 
these damaged proteins is as yet unknown, these results clearly show an increase in oxidatively 
damaged proteins in muscle tissue of CRPS I patients. In patients 2 and 7 showing the highest 
amounts of oxidatively damaged proteins, we found a decreased level of MnSOD (Figure 2). 
Patient 2 also showed the strongest decrease in the MEGS parameters (Table 2). In one AOD 
patient (patient 2) an increased amount of oxidatively damaged proteins was found and the 
amount of MnSOD was more or less increased in five patients and normal in patient 2 (Figure 3).
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MEGS activity in muscle tissue and also in other tissues is dependent on normal oxygen avail­
ability. Under hypoxic conditions, both the oxidation rate of pyruvate and the ATP production 
rate will be decreased due to a decreased oxidation of NADH and FADH2 by the respiratory chain. 
Under these conditions, pyruvate will be converted to lactic acid, resulting in lactic acidosis. 
During chronic and extreme hypoxic conditions, muscle tissue fails to maintain a normal redox 
state. This results in an increased production of reactive oxygen species (ROS), followed by cell 
injury or dysfunction10. CRPS I patients suffer from severe dysfunction of an affected extrem­
ity, sometimes requiring amputation of the affected limb. In this study, we found that venous 
oxygen saturation values, obtained at the level of amputation of the affected limb just prior 
to the surgical procedure, were increased. This is indicative for a decreased oxygen diffusion 
or utilization within the affected limb8. Previously, P-NMR spectroscopy studies have revealed 
a disturbed phosphate/phosphocreatine metabolism in skeletal muscle of the affected limb, 
an indication for mitochondrial dysfunctioning20. In the present study we observed a reduced 
mitochondrial energy generating capacity in muscle tissue of CRPS I patients. In a second group 
of patients, suffering from arterial occlusive disease (AOD), we found that the venous oxygen 
saturation values were either increased or decreased, concluding that also in these patients 
oxygen metabolism is disturbed in the affected limb. However, in this group of patients all the 
MEGS parameters showed normal activities. CRPS I patients react different from AOD patients 
on hypoxic conditions. Moreover, in the CRPS I patients complex II activity was significantly 
decreased compared to the AOD patients. From recent studies it is known that impaired tricar- 
boxylicacid cycle flux, particularly if it is caused by decreased activity of complex II, might result 
in decreased mitochondrial energy production and in overproduction of free radicals. Accu­
mulation of succinate subsequently leads to inhibition of prolyl hydroxylases (PHDs) thereby 
stabilizing hypoxia-inducible factors (HIFs). These HIFs bind to hypoxia-responsive elements so 
activating the transcription of more than two hundred genes that allow cells to adapt to the 
hypoxic condition21. As mentioned before, mitochondrial dysfunction caused by a decreased 
oxygen availability will lead to an increase of ROS, resulting in oxidatively damaged (carbonyl- 
ated) mitochondrial proteins22. In all CRPS I patients, but only in one of the AOD patients, we 
found a varying degree of increase of oxidatively damaged mitochondrial proteins while the 
amount of MnSOD was decreased in two CRPS I patients and more or less increased in five AOD 
patients.
Our observations are compatible with the involvement of free radicals in the pathophysiology 
of CRPS I that has been reported previously5,6. An increase in lipid peroxidation products in 
serum and increased antioxidative products in serum and saliva of CRPS I patients has been 
observed23. Their patients showed increased SOD activity in saliva, so in all probability Cu/Zn- 
SOD instead of the mitochondrial MnSOD. Little is known about the possible genetic background 
of CRPS I. Recently, Higashimoto et al. described eight children with mitochondrial disease and
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clinical features meeting the IASP diagnostic criteria for CRPS I24. In two of them decreased 
respiratory chain complex activities were measured and in six of them the clinical features and 
family history pointed towards a possible mtDNA mutation. In four of their patients mtDNA 
transitions were detected, all known as polymorphisms in the mtDB database25. Whether these 
polymorphisms are risk factors to develop CRPS I is unknown. In our patients we performed 
sequence analysis of the entire mtDNA but found no pathogenic mtDNA mutations (data not 
shown).
In summary, our study is the first to reveal mitochondrial dysfunction and ROS pathology in 
muscle tissue from CRPS I patients. At this moment, it is unclear whether the mitochondrial 
dysfunction that is apparent at the end-stage of CRPS I could also be present in earlier stages of 
the disease, and further studies are needed to obtain an answer to this question. The observa­
tions in muscle from AOD patients indicate that the mitochondrial dysfunction seen in CRPS I is 
not a general phenomenon of severe, hypoxic muscle disease. On the basis of our findings we 
postulate that an impaired mitochondrial energy metabolism is involved in the pathogenesis 
of CRPS I.
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c r ps  i ín ch íld ren
Complex Regional Pain Syndrome type I (CRPS I) is a potentially incapacitating syndrome that 
may occur after a minor injury or operation to a limb. It is a disorder characterized by pain as 
well as sensory and motor disturbances. CRPS I is well-known in adults1 but a relatively new 
diagnostic entity in children. The clinical presentation of CRPS I in children is to some extent 
different from that in adults and may therefore not be recognized in an early stage of the 
disease. In Chapter 2, we provided a retrospective chart review of 78 children (age < 16 years) 
with CRPS type I and compared the data with those of 951 adults with the same syndrome. 
Our study, the largest group of paediatric CRPS I patients evaluated, shows that there are 
significant differences between the two groups. We found that the child population consisted 
predominantly of older girls with a median age of 13 years. Children differed from adults in that 
a lower extremity was involved more frequently, the skin temperature at onset was more often 
lower than the contralateral extremity, and neurological and sympathetic symptoms were less 
pronounced. Treatment protocols currently recommended for children with CRPS I are physi­
cal therapy including advice on posture and movement, stimulation of normal usage of the 
affected extremity, and psychological intervention to reduce fear of movement2. We used a 
protocol with free radical scavengers, vasodilators (if indicated by a lower skin temperature 
in the affected extremity) and physical therapy in these groups. Our study did not lead to firm 
conclusions regarding the optimal treatment strategy for children with CRPS I. Increased aware­
ness of CRPS I in children, familiarity with symptoms, use of diagnostic criteria and, if necessary, 
referral to a clinic with experience in treating children with CRPS I may help alleviate pain and 
suffering and more quickly restore function.
Reported results of treatment of CRPS I in children are usually more favourable than in adults2,3. 
Therefore we investigated quality of life (QoL) in adults who have been treated for childhood- 
onset CRPS I (Chapter 3). Patients with onset of CRPS I in childhood (age < 16 years) completed 
a generic health-related quality of life instrument (SF-36). Results were compared with scores 
in the standard population. We obtained complete SF-36 scores in 54 of 78 patients. Of these, 
12 were still younger than 16 years and were excluded from the study. The median follow-up 
from onset of CRPS I was 12 years (range: 2 - 22). Fifteen patients (33%) experienced one or 
more documented relapses. General health and physical functioning (2 out of 8 scales on the 
SF-36) were significantly lower in patients compared to the standard population. Contrary to 
earlier reports2,3, patients diagnosed with and treated for CRPS I in childhood did not score 
significantly better than adults4. In conclusion, the prognosis of patients with CRPS I onset in 
childhood seems comparable with the prognosis of those diagnosed at adult age.
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The clinical presentation of CRPS I is well-known1,5,6, but the mechanism of the (chronic) pain 
and its underlying pathophysiology still remain unsolved. In the acute phase in adults, CRPS 
I is characterized by symptoms of inflammation in the periphery of the affected extremity. 
Both clinical and experimental evidence support the theory that an excessive regional inflam­
matory response, including production of reactive oxygen and nitrogen species (RONS), may 
contribute to the development of CRPS I and cause tissue damage1,7-9. Leukocytes are thought 
to play a significant role in inflammatory processes. To assess leukocyte accumulation, we 
performed radiolabeled autologous leukocyte scans of both hands in patients with CRPS I of 
one upper extremity after a fracture or an operation of the hand. Results from the affected hand 
were compared with the unaffected contralateral hand (Chapter 4). We found a significantly 
increased accumulation of leukocytes in patients with CRPS I. Free radical-generating capacity 
and release of proteases by leukocytes can contribute to the increased vascular permeability 
observed in CRPS I patients7,10,11. Adherence of leukocytes to endothelial cells may trigger the 
generation of additional free radicals, resulting in an exaggerated inflammatory reaction11,12.
ra d íc a ls
One of the most important features of inflammation is excessive production of reactive oxygen 
and nitrogen species (RONS). We studied the effect of RONS in two known animal models that 
mimic symptoms of CRPS.
In the chronic constriction injury (CCI) rat model13, we investigated levels of oxidative stress 
and antioxidant enzymes in skeletal muscle tissue of the hind paw and (jugular vein) plasma. 
We demonstrated (Chapter 5) that, in skeletal muscle tissue, the level of RONS was lower in 
nerve-injured hind paws than in controls. Plasma level of RONS did not differ between nerve- 
injured and control rats. In skeletal muscle tissue, the level of reduced glutathione (GSH) was 
higher in nerve-injured hind paws than in controls. The ceruloplasmin/transferrin ratio tended 
to be higher in plasma of nerve-injured rats compared to controls. We found that, at day 7 
after nerve injury, oxidative stress-induced changes are present in skeletal muscle tissue of the 
rat hind paw. Our findings of decreased levels of RONS in combination with marked elevation 
of antioxidant enzymes in skeletal muscle and plasma suggest that a surplus of antioxidant 
activity precedes initial oxidative stress. Oxidative stress and antioxidant activity are involved in 
the pathophysiologic mechanisms underlying symptoms in the CCI model, in line with studies 
showing that antioxidants have a beneficial effect on neuropathic pain14,15.
We studied (Chapter 6) the level of RONS in our animal model of continuous intra-arterial infu­
sion of a free radical donor in one hind limb of non-anaesthetized rats16. Infusion of Tertbutyl- 
hydroperoxide (Tert-BuOOH, 25 mM) for 24 hrs in the left hind limb of rats resulted in regional
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symptoms of inflammation and exacerbated sensory responses. We did not find a difference in 
RONS levels between experimental and control animals, or between infused and non-infused 
contralateral hind limbs. Jugular vein plasma levels of ceruloplasmin and tissue levels of GSH 
were found to be higher in infused rats than in controls; this suggests an increased level of 
systemic antioxidant activity that prevents and/or neutralizes free radical formation.
v e n o u s  o xyg en  saturatío n
Increasing evidence points to a role for impaired oxygen metabolism in the affected limb. In 
earlier studies, we found significantly elevated SvO2 levels in blood samples obtained from 
the antecubital vein in the affected upper extremity as compared to SvO2 in the unaffected 
contralateral limb17-19. Therefore we were interested in assessing capillary oxygen and lactate 
levels in the affected limb. In our infusion animal model, we investigated oxygen extraction as 
measured by SvO2 and lactate levels. We found significantly elevated SvO2 levels and a tendency 
toward higher venous lactate levels in the infused hind limb seven days after Tert-BuOOH infu­
sion (Chapter 6). In Chapter 7, we described a pilot study of 16 patients in whom we performed 
capillary blood gas analysis in extremities with acute CRPS I in order to assess oxygen saturation 
and lactate levels. Comparing the affected and unaffected limb as to capillary blood pH, pO2, 
SaO2 and lactate and glucose levels we did not find statistically significant differences. We 
concluded that capillary blood gas analysis is not useful to detect changes in oxygen saturation 
and lactate and glucose levels in CRPS I patients.
In patients with severe CRPS I requiring amputation of the affected limb, we analyzed venous 
blood samples and skeletal muscle specimens (Chapter 8). SvO2 values (mean SvO2 94.5%) were 
significantly higher than in control patients (mean SvO2 83%), and normal values reported in 
the literature (mean SvO2 67.2 to 71.2%19,20), pointing to a severely decreased oxygen diffusion 
or utilization within the affected limb. Skeletal muscle histologic specimens showed changes 
compatible with disuse atrophy. Ultra-structural investigations of skeletal muscle capillaries 
revealed a decrease in capillary density, while endothelial basement membranes were mod­
erately thickened. We conclude from these data that the high SvO2, which suggests defective 
oxygen metabolism, cannot fully be explained by an oxygen diffusion problem resulting from 
decreased capillary densities and/or basement membrane thickening. We therefore hypoth­
esized that the high SvO2 found may also be due to defective oxygen utilization at the mito­
chondrial level. Tert-BuOOH-induced oxidative stress is known to damage mitochondria by 
mitochondrial swelling, resulting in reduction of their respiratory activity21. We have assessed 
mitochondrial function in vitro by stimulating isolated mitochondria in rat skeletal muscle cells 
with increasing doses of Tert-BuOOH. We found that the mitochondrial energy generating sys­
tem, as reflected by State 3 respiration and ATP production, is a target for RONS in this model.
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These data support the concept that Tert-BuOOH induces mitochondrial dysfunction, causing 
impaired oxygen extraction (Chapter 6).
To study our hypothesis in CRPS I patients, we studied mitochondria in affected muscle tis­
sue from amputated limbs of CRPS I patients (Chapter 9). We observed that mitochondria 
obtained from CRPS I muscle tissue display reduced ATP production and substrate oxidation 
rates in comparison to control muscle tissue. There was a relevant correlation between SvO2 
levels and several parameters of the mitochondrial energy generating system. Moreover, we 
found evidence that reactive oxygen species caused damage to mitochondrial proteins and 
reduced manganese superoxide dismutase (MnSOD) levels. These observations indicate that 
mitochondrial dysfunction is involved in the pathophysiology of CRPS I.
On the basis of our findings and those of others, we postulate the following model for the 
pathogenesis of CRPS I: after the triggering event has occurred, the pathological process starts 
with a regional excessive inflammatory response in the area of injury, including the generation 
of reactive oxygen species, leading to excessive pain and impaired function, reduced oxygen 
utilization, mitochondrial dysfunction, and finally to late severe pain, tissue dystrophy and atro­
phy. This model is in agreement with the previously observed positive effects of neutralization 
of reactive oxygen species by radical scavengers,22,23 inhibition of the inflammatory response24 
and physical therapy25,26. Although mechanisms to stimulate the mitochondrial energy gener­
ating system in patients with primary mitochondrial disorders are still limited, new therapies 
are emerging27 and these may be of benefit to CRPS I patients in the future.
g en er a l  d ísc u ss ío n
Our research has focused on the epidemiology, clinical aspects and quality of life in children 
with CRPS I, and on the underlying pathophysiological mechanism of CRPS I in general. In par­
ticular, we have focused on inflammation, oxygen free radicals and venous oxygen saturation. 
In our clinic, children with CRPS I have been treated similarly to adults, according to a treatment 
protocol that includes scavengers, peripheral vasodilators (if indicated by a lower skin tempera­
ture in the affected extremity) and pain medication. Over time, psychological consultation has 
been added, as part of a multidisciplinary approach. Although results have been encouraging, 
we encountered some patients who did not respond well to this treatment protocol.
No studies of scavenger therapy and vasodilators have been published in children with CRPS I. 
We have noted several side effects of vasodilator therapy such as headache and mild hypoten­
sion, both of which also have been observed in adults with CRPS I. Scavenger therapy side 
effects include skin rash and gastrointestinal complaints. Based on the results of our studies 
and the observed side effects of vasodilator and scavenger therapy we currently cannot recom­
mend the use of these therapies in children with CRPS I. As suggested in other studies2,3, we 
modified our treatment protocol to put more emphasis on physical therapy, advice on posture
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and movement, stimulation of normal usage of the affected extremity, and psychological 
intervention to reduce fear of movement.
While previous publications generally show a very favourable prognosis for paediatric-onset 
CRPS I, the results of our case series differ. At long term follow-up, some patients continue to 
experience moderate pain and have modest reductions in quality of life, as found in adults. Our 
treatment strategies using free radical scavengers and vasodilators if indicated have seldom 
been used outside of Europe. It may be argued that these medical interventions have been 
responsible for the less favourable outcome compared to other studies, but we believe this is 
unlikely. In children, a high relapse percentage of 27.5 - 50% was observed28-30. In our study, 
there was a documented relapse percentage of 33%. A prospective study with free radical 
scavengers (and vasodilators if indicated), combined with a quality of life study should be 
conducted in patients with CRPS I in childhood to determine effectiveness in this group. With 
the promising results of the intensive function-oriented physical therapy or Pain Exposure in 
Physical Therapy (PEPT or Macedonian therapy)31, this method is currently being investigated 
in adults with CRPS I, but may also be applicable in children with CRPS I.
The experimental studies in this thesis were performed to obtain insight into the pathophysiol­
ogy of CRPS I, with a focus on inflammation, oxygen free radicals and SvO2. We have found 
increased accumulation of polymorphonuclear leukocytes, the main type of granulocytes seen 
in the acute phase of CRPS I. These are a source of free radicals and release proteases, which 
contribute to increased vascular permeability. Various anti-inflammatory treatments have been 
tested. Blocking TNF seems to have a positive effect32, as does the use of corticosteroids24. The 
use of the antioxidant N-acetyl-l-cysteine was successful in the infusion animal model of free 
radical induced soft tissue injury33 and has also been shown effective in patients23,34. If these 
results are confirmed, these substances may provide alternative treatment options for CRPS I 
patients.
In the chronic constriction injury model of neuropathic pain and the animal model of free 
radical related soft tissue damage, a sensory response with symptoms mimicking CRPS was 
found. We also noted diminished RONS levels in skeletal muscle, and both models showed 
an increased antioxidant status as reflected by elevated systemic levels of ceruloplasmin and 
local GSH levels in skeletal muscle tissue. This effect may be attributed to operative trauma and 
sham surgery in the control group. A wider sampling frame and including more control groups 
would probably have benefited our results. In several studies, RONS are proposed to play an 
important role in chronic pain, and there may be a small and localized increase in RONS levels 
at the injured peripheral nerve and/or spinal cord in chronic conditions14,15. Determining RONS 
and glutathione levels of peripheral nerves in dorsal root ganglia or in the spinal cord in both 
models may be more relevant.
In the animal model of free radical related soft tissue injury, we hypothesized that symptoms of 
chronic pain syndromes are caused by impaired oxygen extraction secondary to RONS-induced
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mitochondrial dysfunction. An argument in favour of our hypothesis on the involvement of 
free radicals in the development of symptoms in this rat model of chronic pain is that, as we 
have shown in a previous study, administration of the free radical scavenger N-acetyl-l-cysteine 
results in reduced pain sensations, reduced skeletal muscle and nerve damage, and shortened 
repair periods33. However, a limitation of our research with regard to our hypothesis concerning 
impaired oxygen extraction is that we did not measure muscle oxygen consumption, muscle 
perfusion or intracellular pO2. We have performed flow measurements with a Transonic (T206)
0.5 V flow probe (0.25 - 0.5 mm vessels), and with the laser Doppler perfusion (Moor High 
Resolution Laser), with a wavelength 633 nm. We could not establish reliable baseline measure­
ments due to technical and logistical difficulties with these apparatus, possibly related to the 
form of anaesthesia used. Validating the model with another form of anaesthesia or other forms 
of oxygen flux measurements (e.g. near infrared spectroscopy) will be important next steps. 
Elevated SvO2 are found also in chronic end-stage CRPS I patients. Comparison of our mea­
surement of SvO2 levels with results in the literature are complicated by several factors, such 
as multiple venous sampling sites from different muscle groups that may vary randomly or 
systematically in their oxygenation state, as well as effects of anaesthesia and surgical exposure 
on local blood flow. Furthermore, investigator bias may be presented in the literature selected 
for comparison. Nevertheless, SvO2 values were significantly increased in all our CRPS I patients, 
compared to an healthy matched control population. Ideally, control skeletal muscle biopsies 
should have been obtained from the unaffected extremity, but such control samples were not 
taken in view of the risk of inducing CRPS I in that extremity. Therefore we have chosen to 
compare our data with data from the literature.
In patients with CRPS I, muscle weakness and exercise-induced pain are present in the affected 
extremity from the beginning1. As the syndrome progresses, CRPS I patients are less able to 
perform skeletal muscle work because less (functional) muscle tissue is present. The resulting 
increased load on the remaining deteriorated muscle fibers gives rise to increased pain upon 
exercise. In this way, in a vicious circle of pain and disuse atrophy results in pseudo-paralysis in 
15% of patients1.
In the present study, we found that patients with severe CRPS I, requiring amputation of the 
affected limb, have a significantly increased SvO2 level in this limb. We also found several abnor­
malities in skeletal muscle tissue compatible with disuse atrophy, including decreased numbers 
of type I fibers and increased numbers of type IIB fibers. Capillary basement membrane thick­
ness was also increased and capillary densities decreased. Based on high saturation levels we 
hypothesized four possibilities: Firstly, a deficient auto-regulation of microcirculation, resulting 
in a widely open capillary bed, while only a small fraction of the oxygen supplied is consumed 
due to hyper-perfusion of some capillaries and inadequate perfusion of others. Secondly, the 
presence of increased flow through non-nutritive pathways, such as through arteriovenous 
anastomoses35. Thirdly, a diffusion problem for oxygen between the erythrocytes and the 
mitochondria, especially the endothelial cell and capillary basement membrane. Finally,
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minimal oxygen extraction due to mitochondrial dysfunction. With respect to the first possibil­
ity, no published reports are available indicating a defective auto-regulation within healthy 
skeletal muscle, poor in mitochondria, resulting in high SvO2 levels. As to the second possibility, 
arteriovenous anastomoses were proven to be present in cat skeletal muscle36, but were not 
found in human temporal skeletal muscle37. Regarding the role of endothelial cells, we found 
significant changes in quadriceps capillaries in relation to the control specimens, such as an 
increase in endothelial cell thickness and in basement membrane thickness. Endothelial cell 
thickness cannot be a factor of importance for oxygen diffusion because capillary diameters, 
measured without the basement membrane, were not significantly different from controls. 
The capillary basement membrane thickness (CBMT) in skeletal muscle in our patients was 
increased by about 33%. This increase in thickness will certainly limit oxygen diffusion during 
maximum exercise. However, this 33% increase in thickness at rest cannot be a factor for tissue 
hypoxia, as oxygen demand at rest is normally 10 times lower than during maximum exercise 
for sedentary people38. Mitochondrial dysfunction is a plausible cause for the high SvO2 levels 
found. Indeed, in a rat model of disuse, an important decrease (3 to 4 times) in mitochondrial 
function was found in the gastrocnemius muscle39. In a comparable experiment with rabbits, 
heavily damaged mitochondria were observed via electron microscopy40. Among our patients, 
a large fraction of the remaining mitochondria may have been damaged or functionally inac­
tive, while their numbers were decreased. We also found loss of mitochondrial activity with 
SDH and ATPase stains. High SvO2 combined with low oxygen extraction is well known in 
sepsis41. Apparently, functionally defective mitochondria cannot optimally metabolize the high 
oxygen supply in this condition, resulting in decreased ATP production even in the presence of 
increased tissue oxygen partial pressures.
Mitochondrial dysfunction may explain the deep skeletal muscle pain during exercise seen in 
CRPS I patients and explains the high SvO2 levels. Our data did not show increased lactate levels 
at rest, but increased levels probably would have been found during exercise. Artificial acidosis 
induced pain in the CRPS I affected extremity only and not in the healthy contralateral extrem­
ity42. This discrepancy can be explained by the additive effect of an already increased level of 
lactate in the affected extremity.
We have observed a reduced mitochondrial energy-generating capacity in muscle tissue of 
CRPS I patients that correlated with the SvO2 values in the affected extremity. Mitochondrial 
dysfunction will lead to an increased production of oxygen radicals, resulting in oxidatively 
damaged (carbonylated) mitochondrial proteins43. In the affected muscle of all patients, we 
found an increase in oxidatively damaged mitochondrial proteins. Our observations are com­
patible with the involvement of free radicals in the pathophysiology of CRPS I, as reported pre­
viously44,45. Future studies may focus on further determination of radical involvement in CRPS I 
by using spin trapping techniques in patients and analyzing and quantifying the mitochondrial 
dysfunction.
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KLiNisCHE EN Fu NDAMENTELE As PECTEN VAN HET Co MPLEx  REGioNAAL 
p ìjn s y n d r o o m  t y pe  i 
ìn le ìd ìn g
Het Complex Regionaal Pijnsyndroom (CRPS), een tot op heden slecht begrepen ziektebeeld, 
is een abnormale reactie in een extremiteit of deel daarvan na een - vaak gering - ongeval of 
na een operatie. Bij ongeveer 10% van de patiënten ontstaat de aandoening spontaan. CRPS 
kan alle weefsels en alle functies van een extremiteit aantasten en kan ernstige invaliditeit en 
moeilijk te behandelen pijn veroorzaken.
Voor dit ziektebeeld worden verschillende benamingen gebruikt, zoals causalgie, algodystro- 
fie, Sudeck-dystrofie, sympathische reflexdystrofie en posttraumatische dystrofie. Omdat tot op 
heden de pathofysiologie niet eenduidig is vastgesteld, wordt het ziektebeeld sinds enige tijd 
benoemd als Complex Regionaal Pijnsyndroom type I (CRPS I) door de International Association 
for the Study of Pain (IASP)1. Men spreekt van CRPS type II (CRPS II) indien er een aantoonbaar 
zenuwletsel aanwezig is.
Dit proefschrift handelt met name over CRPS I, omdat het meer voorkomt dan CRPS II. Het 
klachtenpatroon van een patiënt met CRPS I bestaat voornamelijk uit pijn, die spontaan 
optreedt of ontstaat na een extremiteitletsel dat niet in verhouding staat tot de ernst van het 
letsel. Vroege tekenen zijn: temperatuurverschil, kleurverschil, zwelling, een beperking van de 
functie of beweegbaarheid en krachtverlies. Later optredende tekenen kunnen symptomen 
zijn van zenuwpijn; zoals een brandend gevoel, dysesthesie (overgevoeligheid voor bepaalde 
huidprikkels), paresthesie (onjuiste gevoelsgewaarwording), mechanische allodynie (stoornis 
in de pijngewaarwording) en hyperalgesie (verhoogde gevoeligheid voor pijn), of symptomen 
van autonome dysfunctie; zoals cyanose (blauwe verkleuring van de huid), mottling (vlekkerig 
worden van de huid), hyperhidrosis (transpireren), oedeem (zwelling), koude van de extremiteit 
en verandering in haargroei.
Dit proefschrift concentreert zich op:
- De klinische presentatie en prognose van CRPS I bij kinderen en volwassenen;
- Enkele fundamentele aspecten van ontsteking in CRPS I; (1) de rol van zuurstofradicalen in 
humane en proefdierstudies, (2) de rol van veneuze zuurstofsaturatie en factoren verant­
woordelijk voor zuurstofdiffusie.
s a m e n v a t t ìn g
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HET c o m plex  REGioNAAL P ìjn sy n d r o o m  t y pe  i BiJ KiNDEREN
CRPS I verloopt bij kinderen ten dele anders dan bij volwassenen en wordt hierdoor vaak niet 
herkend. In Hoofdstuk 2 van dit proefschrift beschrijven we een onderzoek bij 78 kinderen 
met CRPS I (leeftijd < 16 jaren) en vergelijken we het ziektebeeld met 951 volwassen CRPS I 
patiënten. De gemiddelde leeftijd bij presentatie ligt tussen de 11 en 14 jaar, gemiddeld 13 
jaar. Net zoals bij volwassenen komt CRPS I bij kinderen vaker voor bij het vrouwelijke geslacht. 
CRPS I bij kinderen wijkt in enkele opzichten af van het ziektebeeld bij volwassenen. Bij kinde­
ren is bij aanvang van het ziektebeeld het aangedane ledemaat meestal kouder dan het andere 
niet aangedane ledemaat, en is de onderste extremiteit vaker aangedaan (60 - 87%) dan de 
bovenste.
De medische behandeling bij volwassenen is gericht op remming van de ontsteking, pijnstil- 
ling en, bij koude CRPS I, verbeteren van de perifere doorbloeding en het geven van hou- 
dings- en bewegingsadviezen. Tegenwoordig wordt meer aandacht besteed aan fysiotherapie 
en verbetering van de functie van de aangedane extremiteit. Ook bij kinderen wordt naast 
de ontstekingsremmende behandeling en de psychologische begeleiding, de fysiotherapie 
meer en meer benadrukt. Verscheidene behandelmodaliteiten worden beschreven met wis­
selende resultaten. De meeste onderzoeken betreffen echter kleine patiëntengroepen dan wel 
casuïstische mededelingen. Consensus over behandeling van CRPS I bij kinderen bestaat niet. 
Ook onze resultaten laten niet zien welke behandeling voor CRPS I bij kinderen het beste is. 
Toekomstig onderzoek zal dit moeten uitwijzen.
Bij kinderen met pijnklachten van het houdings- en bewegingsapparaat dient CRPS I in de 
differentiaaldiagnose te worden opgenomen. Alertheid met betrekking tot de diagnose en 
het volgen van een protocol zijn de sleutel tot de behandeling van kinderen met CRPS I. Bij 
ernstige klachten is snelle verwijzing gewenst naar een specialist of een specialistische groep 
die ervaring heeft met deze aandoening.
Volgens de literatuur is de prognose van CRPS I bij kinderen vaak beter dan bij volwassen2-4. In 
Hoofdstuk 3 hebben wij de kwaliteit van leven onderzocht bij volwassenen die op kinderleef­
tijd behandeld zijn voor CRPS I. Deze groep patiënten heeft een standaard vragenlijst ingevuld, 
waarvan de resultaten werden vergeleken met die van de algemene bevolking. Wij ontvingen 
een compleet ingevulde enquête van 54 van de 78 patiënten. Van deze groep waren 12 patiën­
ten jonger dan 16 jaar. Zij zijn niet meegenomen in de studie. De gemiddelde follow-up sinds 
het ontstaan van CRPS I op kinderleeftijd bedroeg 12 jaren (2 - 22 jaren). Vijftien patiënten (33%) 
beschreven een of meer recidieven. Twee items van de kwaliteit-van-leven-studie, algemene 
gezondheid en fysiek functioneren, scoorden slechter dan bij de gemiddelde bevolking. Wij 
kwamen tot de conclusie dat de prognose van patiënten met CRPS I op kinderleeftijd vergelijk­
baar is met volwassenen die op latere leeftijd CRPS I hebben gekregen. Dit in tegenstelling tot 
wat algemeen wordt aangenomen.
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De klachten waarmee patiënten met CRPS I zich presenteren zijn algemeen bekend5-7, maar 
het onderliggende ziektemechanisme van met name de chronische pijn blijft onopgehelderd. 
In de acute fase wordt CRPS I bij volwassenen gekarakteriseerd door tekenen van ontsteking 
in het aangedane ledemaat. Zowel klinisch als experimenteel onderzoek ondersteunen de 
theorie dat een overmatige locale ontstekingsreactie, inclusief de productie van actieve 
zuurstof en stikstofradicalen, betrokken zijn bij het ontstaan en ontwikkelen van CRPS I en 
verantwoordelijk zijn voor de geobserveerde weefselschade5,8-10. Een radicaal is een vrij atoom 
of molecuul dat veel schade kan aanrichten. Witte bloedcellen spelen een belangrijke rol in 
allerlei ontstekingsreacties. Om een eventuele stapeling van witte bloedcellen te beoordelen in 
een aangedaan ledemaat, hebben wij witte bloedcellen radioactief gelabeld en scans gemaakt 
van beide handen en polsen van patiënten die aan een van deze bovenste extremiteiten CRPS I 
hebben ontwikkeld na een botbreuk of een operatie. Op basis van deze scans werd een verge­
lijking gemaakt tussen de aangedane en niet aangedane zijde (in Hoofdstuk 4).
Wij vonden een significant verhoogde stapeling van witte bloedcellen bij patiënten met CRPS
I. De vrije zuurstofradicalen genererende capaciteit en het vrij maken van diverse schadelijke 
enzymen door witte bloedcellen zijn verantwoordelijk voor de verhoogde doorlaatbaarheid 
van de vaatwand, zoals men heeft kunnen waarnemen bij patiënten met CRPS I8,11,12. Vastkle­
ven van witte bloedcellen aan cellen van de vaatwand kan leiden tot additionele vrije radicalen 
en resulteren in een overmatige onstekingsreactie12,13.
ra d ìc a len
Een belangrijk onderdeel van ontsteking is het vrijkomen van een overmatige hoeveelheid 
reactieve zuurstof en stikstof radicalen. Wij hebben het effect van deze reactieve zuurstof 
en stikstofradicalen bestudeerd in twee diermodellen, die symptomen laten zien die over­
eenkomen met het klinisch beeld van CRPS. In het chronische constrictie ratmodel14 wordt 
een ligatuur rondom de zenuw (nervus ischiadicus) naar de achterpoot van de rat gelegd. 
Wij onderzochten in dit model de mate van oxidatieve stress en de aanwezigheid van anti­
oxidanten (stoffen die ongewenste oxidatie en vrije radicaalvorming kunnen voorkomen, 
zogenaamde vrije radicaalvangers) in spierweefsel van de aangedane achterpoot van de rat en 
in plasma afkomstig van de vena jugularis (halsader). Wij hebben in Hoofdstuk 5 aangetoond 
dat bij ratten, in spierweefsel het niveau van de zuurstof- en stikstofradicalen lager was in de 
aangedane poot ten opzichte van normale ratten. Er was geen verschil in reactieve zuurstof- en 
stikstofradicalen in het plasma. In spierweefsel vonden wij dat het niveau van het lichaams­
eigen antioxidant glutathion hoger was bij aangedane ratten dan bij normale ratten. In het 
plasma bleek het antioxidantniveau ook veel hoger te zijn bij aangedane ratten ten opzichte
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van normale ratten. Ook zagen wij na 7 dagen zichtbare veranderingen die passen bij door 
zuurstofradicalen geïnduceerde weke delenschade in de achterpoot van de rat. Deze bevin­
dingen van lagere waarden van zuurstofradicalen in combinatie met een duidelijk verhoging 
van de antioxidanten in zowel spierweefsel als plasma suggereren dat deze verhoging wel­
licht voorafgegaan is door oxidatieve stress (aanwezigheid van een overmatige hoeveelheid 
reactieve zuurstofverbindingen). Oxidatieve stress en een verhoogde antioxidantactiviteit zijn 
betrokken in het ziektemechanisme in dit chronische constrictie ratmodel, wat in overeenstem­
ming is met andere studies waar antioxidanten een gunstig effect hebben op zenuwpijn15,16.
In Hoofdstuk 6 onderzochten wij een ander diermodel, waarbij continu de vrije radicaal donor 
tertbutyl-hydroperoxide (Tert-BuOOH) werd geïnfundeerd in een achterpoot van wakkere 
ratten17. Infusie van Tert-BuOOH (in een dosis van 25 mM) gedurende 24 uur in de linkerachter­
poot van een rat, resulteerde in symptomen en verschijnselen van een overmatige sensorische 
reactie, passend bij CRPS I. Wij vonden geen verschil tussen experimentele en niet behandelde 
ratten voor wat betreft reactieve zuurstof- en stikstofdeeltjes, noch tussen de geïnfundeerde 
en niet-geïnfundeerde achterpoot. Het endogene antioxidant ceruloplasmine in plasma uit de 
vena jugularis en glutathion uit spierweefsel waren hoger in de aangedane poot in vergelijking 
met normale ratten. Dit suggereert een verhoogde systemische antioxidantactiviteit, die wel­
licht vrije radicaalformatie verhindert.
v e n e u z e  z u u rst o fsa tu ra t ìe
Er bestaan steeds meer aanwijzingen dat bij CRPS I sprake is van een verstoring in het zuur- 
stofmetabolisme in het aangedane ledemaat. In enkele studies uit het verleden vonden wij 
verhoogde veneuze zuurstofsaturatie (SvO2) waarden in bloed dat werd afgenomen uit de vena 
cubiti (elleboogsvene)18-20. Daarom waren wij geïnteresseerd in het bepalen van de capillaire 
zuurstof en lactaatspiegels in het aangedane ledemaat. Wij onderzochten in ons infusiedier- 
model de zuurstofextractie, die werd bepaald door SvO2- en lactaatspiegels. Wij vonden een 
significant verhoogde SvO2-spiegel en een tendens naar hogere veneuze lactaatwaarden in 
de geïnfundeerde ledemaat, 7 dagen na Tert-BuOOH-infusie (Hoofdstuk 6). In Hoofdstuk 7, 
beschrijven we een pilotstudy van 16 patiënten bij wie wij een capillaire bloedgasanalyse heb­
ben verricht in extremiteiten met acute CRPS I. Vergelijking van capillaire bloeduitslagen pH, 
pO2, SaO2, lactaat en glucose tussen de aangedane en niet aangedane ledemaat, toonde geen 
statistische significante verschillen. Wij concluderen hieruit dat de capillaire bloedgasanalyse 
niet nuttig is om verandering in zuurstofsaturatie en lactaatspiegels te detecteren in patiënten 
met CRPS I.
Bij patiënten die vanwege een zeer ernstige CRPS I een amputatie van het aangedane extre­
miteit moesten ondergaan, hebben wij veneuze bloedgassen en spierbiopten onderzocht 
(Hoofdstuk 8). De SvO2 waarden (gemiddeld SvO2 van 94,5%) waren significant hoger dan bij
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controlepatiënten (gemiddeld SvO2 van 83%), en ook hoger dan normaalwaarden die beschre­
ven zijn in de literatuur (gemiddelde SvO2 waarde tussen 67,2 tot 71,2%)20,21. Dit wijst in de 
richting van een ernstig verminderde zuurstofdiffusie en verbruik in de aangedane extremiteit. 
Skeletspierbiopten tonen verandering die passen bij inactiviteitsatrofie. Onderzoek van de 
capillairen in de skeletspier tonen een verminderde capillaire dichtheid, terwijl de endotheliale 
basaalmembraan verdikt is. Beiden kunnen de gevonden hoge SvO2, niet helemaal verklaren. 
Wij hypothetiseren daarom dat de hoge SvO2 tevens wordt veroorzaakt door een probleem in 
het zuurstof verbruik op mitochondriaal niveau.
Bekend is dat Tert-BuOOH geïnduceerde oxidatieve stress in staat is mitochondria te beschadi­
gen door zwelling, waardoor er een vermindering optreedt van de respiratoire capaciteit22. Wij 
hebben de mitochondriële functie in vitro onderzocht door geïsoleerde mitochondria van rat­
tenspieren te stimuleren met oplopende doses Tert-BuOOH. Wij vonden dat het mitochondriële 
energie genererende systeem het doelwit is van zuurstof- en stikstofradicalen in dit model. 
Deze data ondersteunen de gedachte dat Tert-BuOOH in staat is tot mitochondriële dysfunctie, 
leidend tot een verminderde zuurstofextractie (Hoofdstuk 6). Om onze hypothese bij patiënten 
met CRPS I te onderzoeken, analyseerden wij mitochondria van aangedane spieren van patiën­
ten die een amputatie moesten ondergaan in verband met ernstige CRPS I (Hoofdstuk 9).
De mitochondria van deze patiënten tonen een verminderde ATP-productie en substraat- 
oxidatie-ratio in vergelijking met controlespieren. Er is een duidelijke correlatie tussen de 
SvO2 en diverse parameters van het mitochondriële energie genererende systeem. Ook vonden 
wij bewijs dat reactieve zuurstofdelen belangrijke mitochondriële eiwitten beschadigen en 
resulteren in een verminderde hoeveelheid van het antioxidant enzym manganese superoxide 
dismutase (MnSOD). Deze observaties wijzen erop dat mitochondriële dysfunctie een belang­
rijke rol speelt in het ziektemechanisme van CRPS I.
Op basis van onze bevindingen en van andere studies postuleren wij het volgende model, dat 
verantwoordelijk is voor de pathogenese van CRPS I:
Nadat er een triggering event (uitlokkend moment) heeft plaatsgevonden, start het proces 
met een overmatige regionale ontstekingsreactie in het gebied rondom het oorspronkelijke 
letsel. Hierdoor worden reactieve zuurstofdeeltjes gegenereerd die verantwoordelijk zijn voor 
pijn, verminderde functie, verminderde zuurstofverbruik, mitochondriële dysfunctie en uitein­
delijke tot late chronische pijn, weefseldystrofie en atrofie. Dit model is in overeenstemming 
met eerdere beschreven positieve effecten ter neutralisatie van reactieve zuurstofdeeltjes door 
middel van radicaalscavengers (zuurstofradicaalwegvangers)23,24, inhibitie van het ontstekings- 
proces25 en fysiotherapie26,27. Hoewel de mogelijkheden beperkt zijn om het mitochondriële 
energie genererende systeem in patiënten met primaire mitochondriële ziekten te stimuleren, 
zijn er nieuwe therapieën op komst28, welke wellicht in de toekomst van nut kunnen zijn voor 
patiënten met CRPS I.
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